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Chondrolectin (Chodl) is needed for motor axon
extension in zebrafish and is dysregulated in mouse
models of spinal muscular atrophy (SMA). However,
themechanistic basis ofChodl function is not known.
Here, we use Chodl-deficient zebrafish and mouse
mutants to show that the absence of Chodl leads to
anatomical and functional defects of the neuromus-
cular synapse. In zebrafish, the growth of an identi-
fied motor axon beyond an ‘‘en passant’’ synapse
and later axon branching from synaptic points are
impaired, leading to functional deficits. Mechanisti-
cally, motor-neuron-autonomous Chodl function de-
pends on its intracellular domain and on binding
muscle-derived collagen XIXa1 by its extracellular
C-type lectin domain. Our data support evolutionarily
conserved roles ofChodl in synaptogenesis and pro-
vide evidence for a ‘‘synapse-first’’ scenario of motor
axon growth in zebrafish.INTRODUCTION
In zebrafish, three primary motor axons grow out on a common
mid-segmental pathway to the horizontal myoseptum, where
axons pause and only the axon of the caudal primary motor
neuron (CaP) continues its ventral growth (Beattie et al., 2002;
Myers et al., 1986;Westerfield et al., 1986). Although the horizon-
tal myoseptum is a decision point for axon pathfinding, it is also a
major synaptic site, where axon growth pauses and axons form
the first synapses with so-called muscle pioneers. Contact with
the muscle pioneers is not necessary for growth of the CaP axon
ventral to the horizontal myoseptum, as shown by ablation of
muscle pioneers (Melançon et al., 1997). However, it is unknown
whether proper formation of this ‘‘en passant’’ synapse is neces-
sary for the CaP axon’s growth cone to be able to escape the1082 Cell Reports 29, 1082–1098, October 29, 2019 ª 2019 The Auth
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et al., 2005). Similarly, growth of new axon branches originates
from and depends on synaptic points, e.g., in Xenopus motor
axon arborization (Javaherian and Cline, 2005), arborization of
retinal ganglion cell axons in zebrafish (Meyer and Smith,
2006), or the thalamo-cortical projection in mammals (Matsu-
moto et al., 2016). Hence, both CaP axon extension beyond an
en passant synapse and axon branching could depend on syn-
apse stabilization in zebrafish, whereas in mammals, motor
axon growth mostly precedes terminal synaptogenesis (Sanes
and Lichtman, 1999).
Chondrolectin (Chodl) is a cell surface recognition molecule
expressed by motor neurons in zebrafish (Zhong et al., 2012)
and is selectively expressed in ‘‘fast’’ motor neurons in mice (En-
jin et al., 2010). Knock down of chodl in zebrafish leads to pro-
longed stalling of CaP axons at the horizontal myoseptum while
leaving axon pathfinding and overall axon growth speed unaf-
fected (Zhong et al., 2012). However, the exact mechanism of
Chodl action is unknown.
Chodl is also dysregulated in an spinal muscular atrophy
(SMA) mouse model at an early stage, before detectable mus-
cle weakness (Bäumer et al., 2009; Zhang et al., 2008), and is
highly expressed in the most vulnerable motor neurons in an
amyotrophic lateral sclerosis (ALS) model (Martı́nez-Silva
et al., 2018; Wootz et al., 2010). Overexpression of chodl
partially rescues motor axon patterning defects observed in a
zebrafish SMA model (Sleigh et al., 2014a), suggesting func-
tions of Chodl in motor neuron disease pathology. We hypoth-
esize that, in vertebrates, Chodl is necessary for synaptic
differentiation and, thus, drives motor axon growth and arbori-
zation in zebrafish.
Here, we show that, in both embryonic zebrafish and postnatal
mice, synaptogenesis is specifically impaired in the absence of
chodl. We demonstrate that Chodl directly interacts with
collagen XIX1a (ColXIX1a) in the extracellular matrix to exert its
function. Hence, Chodl is essential for proper neuromuscular
junction differentiation in vertebrates and necessary for CaP
axon extension and motor axon branching in zebrafish.ors.
commons.org/licenses/by/4.0/).
RESULTS
To determine evolutionarily conserved functions of chodl, we
analyzed phenotypes of zebrafish and mouse Chodl mutants,
followed by protein function analysis.
Generation of a Zebrafish chodl Mutant
For mutagenesis, we used CRISPR technology on the back-
ground of a transgenic reporter line in which GFP is expressed
under the regulatory sequences of the mnx1 gene (also known
as hb9) to visualize motor neurons (Flanagan-Steet et al.,
2005). Injecting three independent guide RNAs (gRNAs) induced
exaggerated stalling of the CaP axon at the horizontal myosep-
tum in a mosaic fashion (Figures S1A and S1C). Using one effi-
cient gRNA (Figure S1D), we generated a stable mutant with a
4-base pair deletion in the open reading frame near the start
codon, leading to a predicted STOP in position 10 of the 236-
amino-acid-long protein (Figure S1B), preventing translation of
C-type lectin and transmembrane domains. Predicted stop co-
donsmay lead to non-sense-mediated decay of the RNA (Ander-
son et al., 2017). Indeed, mRNA expression was reduced by a
third in qRT-PCR (Figures S1G, S1I, and S1J). However, poten-
tially truncated forms of the protein could still exist. Homozygous
mutants were adult viable and did not show alterations of body
size, eye size, or muscle development in embryos (Figures S1E
and S1F). In contrast, 73% (99 of 136 motor axons in 17 em-
bryos) of motor axons were stalled at the horizontal myoseptum
at 28 h post fertilization (hpf), whereas in wild-type embryos, all
axons (128 of 128 motor axons in 16 embryos) had grown
beyond that point (data not shown). Axons were always as-
sessed on one side of the embryo in segments 7–14. In a
different set of embryos, motor axon length was reduced by
58% in the mutant (Figures 1A and 1B). Middle primary motor
neuron (MiP) axons were also shorter in the mutant (Figures
S1K–S1M). This replicates the chodl morpholino phenotype
(Zhong et al., 2012) and confirms that we generated a chodl ze-
brafish mutant with disrupted gene function.
Correct Gene Expression Level of chodl Is Required in
Zebrafish Motor Neurons
Next, we addressed whether stalling of CaP axons at the hori-
zontal myoseptum in chodl mutants was motor neuron autono-
mous and whether the introduced mutation led to a loss of
gene function. To that aim, we generated a transgenic line on
the background of the chodl mutant (with mnx1:GFP transgene)
that selectively overexpressed FLAG-tagged chodl inmotor neu-
rons under the regulatory sequences ofmnx1. Overlap of FLAG-
tag immunoreactivity and GFP signal in mnx1:GFP transgenic
animals confirmed correct targeting (Figure 1A). In this line,
designated (chodl/; mnx1:chodl-FLAG), the stalled axon
phenotype was completely rescued (Figures 1A and 1B). Hence,
the short CaP axon phenotype is a loss-of-function mutation and
is cell autonomous for motor neurons.
To determine if excess chodl expression in motor neurons
altered axon growth, we injected the mnx1:chodl-FLAG
construct into wild-type zygotes. This adds additional chodl
expression to the wild-type levels. At 28 hpf, chodl-FLAG-ex-
pressing axons were reduced in length by 39% compared tovector-injected control axons and by 39% compared to FLAG-
negative axons in the same animals, as an internal negative con-
trol. (Figures 1C and 1D). Although relatively few embryos
showed transfected CaP neurons, statistical power was 0.999,
indicating robustness of results. The same was true when
CaPs were considered individually (Figure S1H). Therefore,
both increased and reduced levels of chodl expression in motor
neurons impair axon growth in a cell-autonomous manner.
Lack of chodl Impairs Synaptogenesis during Early CaP
Axon Growth
Lack of chodl only affects CaP axon growth by prolonging
stalling at the horizontal myoseptum, a major synaptic site with
muscle pioneers (Zhong et al., 2012). Synaptic sites may be
important for the growth of exploratory filopodia and as a starting
point for axon branching (Javaherian and Cline, 2005; Panzer
et al., 2006). We tested whether filopodia dynamics were altered
for CaP axons by using video time-lapse microscopy of CaP
growth cones at the horizontal myoseptum. Filopodia, visualized
with the F-actin binding Lifeact peptide (Riedl et al., 2008), were
not changed in number and average survival time in the mutant
(Figures S2A–S2E). Hence, a lack of chodl does not detectably
affect filopodia dynamics.
Next, we tested whether synaptogenesis would be affected in
the chodl mutant. Analyzing the horizontal myoseptum synaptic
site with the Znp-1 antibody to the pre-synaptic protein Synap-
totagmin 2 (Syt2) (Wen et al., 2010) at 28–29 hpf, we found that
the total area of Syt2 immunoreactivity was enlarged by 30%
in the mutant compared to wild-type controls (Figures 2A and
2B). As an additional measure of pre-synaptic differentiation,
we determined whether immuno-reactivity clustered into appro-
priate puncta. Puncta were defined as distinct structures of high
immunoreactivity for pre-synaptic, post-synaptic, or both
markers. Instead of forming discernible pre-synaptic puncta at
the horizontal myoseptum (2.61 puncta/hemisegment in con-
trols), enlarged puncta were not clearly separated from each
other, leading to the detection of fewer of these in the mutant
(1.55 puncta/hemisegment; Figure 2E). Intensity of immuno-
reactivity was also increased by 57% in the mutant (Figure 2H).
All of these parameters were rescued to wild-type levels in the
(chodl/; mnx1:chodl-FLAG) line (Figures 2B, 2E, and 2H).
Using antibodies to Synaptic Vesicle glycoprotein 2 (SV2) to
label the pre-synaptic area, we found no change in total area
but saw a similar reduction in the number of discernible puncta
per hemisegment that was rescued in the (chodl/;
mnx1:chodl-FLAG) line (Figures S3A–S3C). Hence, differentia-
tion of pre-synaptic structures is disrupted by a lack of Chodl
in motor neurons.
The total post-synaptic area, labeled with antibodies to acetyl-
choline receptors (anti-AChR), was not significantly altered in
chodl mutants (Figure 2C). However, the number of discernible
post-synaptic AChR+ puncta was reduced from 3.98 puncta/
hemisegment in controls to 2.84 in mutants and rescued in the
(chodl/; mnx1:Chodl-FLAG) line (Figure 2F). The labeling in-
tensity of AChR was not affected in the mutant but was 16%
lower in the (chodl/; mnx1:chodl-FLAG) line than in controls
(Figure 2I), perhaps due to inadequate levels of Chodl being
achieved in the rescue line. Overall, this means that clusteringCell Reports 29, 1082–1098, October 29, 2019 1083
Figure 1. Precise Levels of Chodl Are Needed in CaP Motor Neurons for Unimpeded Axon Growth
Lateral trunk views of zebrafish embryos at 28 hpf are shown. Dashed lines indicate the horizontal myoseptum (HM).
(A) Motor axons are stalled at the horizontal myoseptum in chodlmutants. Axon length is restored by stable transgenic expression of FLAG-tagged Chodl inmotor
neurons of mutants in the (chodl/; mnx1:chodl-FLAG) line.
(B) Quantification of axon lengths of F2 (chodl/; mnx1:chodl-FLAG) embryos without FLAG immuno-histochemistry are shown (****p < 0.0001; statistical
power = 1.00).
(C) Acute, mosaic expression of mnx1:chodl-FLAG in wild-type embryos leads to reduced growth of FLAG+ (arrowhead in C) but not FLAG axons in the same
embryos or in embryos injected with the empty vector.
(D) Quantification of CaP axon length from mosaic expression of mnx1:chodl-FLAG in wild-type embryos (****p < 0.0001; statistical power = 0.999).
Scale bars, 50 mm; each data point represents one animal; data are represented as mean ± SEM; n.s., not significant.
See also Figures S1 and S2.
1084 Cell Reports 29, 1082–1098, October 29, 2019
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of post-synaptic AChR+ puncta is affected by a lack of pre-syn-
aptic Chodl.
To determine the synaptic area, we measured the overlap of
pre-synaptic (anti-Syt2) and post-synaptic (anti-AChR) labeling.
The total synaptic area was increased by 42% in themutant, and
the number of discernible synaptic puncta per hemisegment was
decreased from 3.55 to 2.24. Both measurements were rescued
in the (chodl/; mnx1:chodl-FLAG) line (Figures 2D and 2G).
Hence, mutating chodl in motor axons disrupts synaptic differ-
entiation on muscle pioneers at the horizontal myoseptum.
Next, we askedwhether synapsematuration was only delayed
in chodl mutants or whether defects persisted even when the
axons had grown beyond the horizontal myoseptum. In older
embryos (31 hpf), we analyzed the synaptic phenotype only in
hemisegments with axons that had grown beyond the horizontal
myoseptum in the mutant. Pre-synaptic labeling area (anti-Syt2)
was not increased, but the number of discernible puncta per
hemisegment was reduced from 2.91 to 2.14 (Figures S3G,
S3H, and S3L), and the labeling intensity was increased (by
58%; Figure S3K) compared to wild-type controls. Anti-SV2 la-
beling showed an increased total pre-synaptic area and reduced
number of discernible puncta per axon (Figures S3D–S3F).
Post-synaptic labeling of AChR showed no changes in total
area and discernible cluster number per hemisegment but
showed a slightly increased labeling intensity by 22% (Figures
S3I, S3M, and S3O). The synaptic area was increased by 51%,
and the number of discernible synaptic puncta per hemisegment
was reduced from 3.60 to 2.66 (Figures S3J and S3N). Hence,
similar pre-and post-synaptic aberrations and an increase of
synaptic area were present at the horizontal myoseptum for
axons stalled at the horizontal myoseptum and those that had
grown beyond this point. This suggests that eventual ‘‘escape’’
of CaP axons from the horizontal myoseptum is not associated
with full normalization of synapse morphology.
Lack of chodl Impairs Axon Branching in Zebrafish
After 48 hpf, motor axons branch onto the muscle, and it has
been shown in Xenopus that this depends on synapse formation
(Javaherian and Cline, 2005). Axons only form new branches at
synaptic sites in Xenopus. Analyzing axon branching onto myo-
tomes at 3 dpf in zebrafish, we find that 97% of axonal branchFigure 2. CaP Axons of chodl Mutants Show Pre- and Post-Synaptic D
(A) Motor neurons of mnx1:GFP transgenic animals are green. Znp-1 antibody lab
measurement areas. Scale bar, 10 mm.
(B and E) Pre-synaptic puncta at the horizontal myoseptum (HM) are enlarged (B
(E; discernible puncta). These parameters are rescued in the (chodl/; mnx1:c
statistical power = 0.9977).
(C and F) Post-synaptic puncta area at the horizontal myoseptum is unchanged
compared to wild-type animals (F; discernible puncta). This parameter is rescue
tistical power = 0.9996).
(D) Synaptic area is increased in the mutant and rescued in in the (chodl/; mn
(G) The number of discernible synaptic puncta is reduced in the mutant and rescu
0.999).
(H) Intensity of Znp-1 labeling is increased in chodl mutants compared to wild-typ
power = 0.9918).
(I) The mean intensity of AChR labeling is decreased the (chodl/; mnx1:chod
statistical power = 0.9097).
Each data point represents one animal; data are represented as mean ± SEM; n
See also Figure S3.
1086 Cell Reports 29, 1082–1098, October 29, 2019points coincide with synaptic puncta (429 of 443 branch points
in 10 larvae; Figures S4A and S4B), suggesting similar mecha-
nisms in zebrafish. Therefore, we hypothesized that in chodlmu-
tants, axon branching and synaptogenesis onto the myotomes
should be impaired.
We analyzed axon branching and synapse formation in chodl
mutants at 3 dpf, whenmotor axons are highly branched over the
myotomal surface in wild-type animals. Mid-segmental nerve
trunks were present in chodl mutants but showed strongly
reduced branching on the muscle tissue (Figure 3A). To quantify
myotomal innervation, we labeled synaptic puncta, defined as
puncta of AChR immuno-reactivity with an overlying SV2+
puncta (Figures 3B–3J). The number of synaptic puncta on the
muscle surface in the mutant was reduced by 72.5%. This was
partially rescued in the (chodl/; mnx1:chodl-FLAG) line, with
a reduction by 26.1%, compared to synapse numbers observed
in wild-type control animals (Figure 3K). Overall, chodl mutants
show an axon-autonomous impairment of axon branching and
synaptogenesis on the muscle tissue. Muscle pioneers, the first
muscle cells the CaP axon forms synapses with, develop into
slow muscle fibers. That process is complete at 2 to 3 weeks
of development (Devoto et al., 1996). Hence, we cannot assess
the specific roles of chodl for fast versus slow muscle fibers in
zebrafish from the above data on the immature system.
The Touch-Evoked Escape Response Is Impaired in
Zebrafish Larvae
The earliest motor axon/muscle interactions take place at 18–19
hpf, before CaP axons reach the horizontal myoseptum. At this
time point, coiling behavior occurred at a frequency that was un-
altered in chodl mutants compared to wild-type embryos (Fig-
ure S4C). This indicates the absence of an early movement
phenotype in chodl mutants.
To determine whether the observed axonal branching pheno-
types are correlated with behavioral deficits, we used a touch
assay to quantify escape reactions of larvae at 3 dpf. Despite
hypo-innervation of trunk musculature, larvae swam the same
distance after touching their tail (Figures S4D and S4E). How-
ever, high-speed analysis of the C-bend turning reaction after
a head touch (Figure 3L) indicated that the initial escape angle
of chodlmutants was reduced from 144 to 105 degrees, resultingefects at the Horizontal Myoseptum
els the pre-synapse and AChR the post-synapse. Yellow squares indicate the
, total area) and fewer individual puncta can be identified in the chodl mutant
hodl-FLAG) line (B, ****p < 0.0001, statistical power = 1.00; E, ****p < 0.0001;
(C, total area), but fewer individual puncta are detected in the chodl mutant
d in the (chodl/; mnx1:chodl-FLAG) line. (****p < 0.0001, **p = 0.0012; sta-
x1:chodl-FLAG) line (****p < 0.0001, ***p = 0.0005; statistical power = 0.9978).
ed in the (chodl/; mnx1:chodl-FLAG) line (****p < 0.0001; statistical power =
e control and the (chodl/; mnx1:chodl-FLAG) line (***p = 0.0002; statistical
l-FLAG) line compared to wild-type control and chodl mutants (***p = 0.0010;
.s., not significant.
Figure 3. Chodl Is Necessary for Axon
Branching onto the Myotome Surface and
Proper Escape Response
Lateral trunk views are shown.
(A)mnx1:GFP+motor nerves are present along the
mid-segmental pathway (ventral motor nerves,
black arrowheads) but lack branching onto the
myotome in chodl mutants at 3 dpf.
(B) SV2 immunohistochemistry in wild-type
zebrafish.
(C) SV2 immunohistochemistry in chodl mutant.
(D) SV2 immunohistochemistry in the (chodl/;
mnx1:chodl-FLAG) line is shown.
(E) AChR immunohistochemistry in wild-type ze-
brafish is shown.
(F) AChR immunohistochemistry in the chodl
mutant is shown.
(G) AChR immunohistochemistry in the (chodl/;
mnx1:chodl-FLAG) line is shown.
(H) Overlap of SV2 and AchR labeling in wild-type
zebrafish is shown.
(I) Overlap of SV2 and AchR labeling in chodl
mutant is shown.
(J) Overlap of SV2 and AchR labeling in (chodl/;
mnx1:chodl-FLAG) line is shown. The density of
synapses (overlap of SV2 and AChR labeling) on
the surface of the myotomes is reduced in chodl
mutants compared to controls and is partially
rescued in the chodl-FLAG rescue line. Regions of
analysis (red boxes) are shown in higher magnifi-
cation as insets.
(K) The number of synapses is reduced in
chodl/ larvae compared to controls and
partially rescued in the (chodl/; mnx1:chodl-
FLAG) line (****p < 0.0001, *p = 0.0419; statistical
power = 0.9999). Scale bars, 50 mm. Insets scale
bar, 10 mm.
(L) Cartoon shows starting position of the larvae
and the C-bend, which can be randomly to the left
or right after tapping the head and the angle is
measured.
(M) Representative frames of high-speed
recording of the touch-evoked escape response
are shown for wild-type control, chodl mutants,
and (chodl/; mnx1:chodl-FLAG) animals.
Turning movements of larvae are indicated by red
arrows (arrowhead indicates head). Scale bars,
4 mm.
(N) The turning angle is reduced in mutant larvae,
compared to wild-type animals and rescued in the
chodl/; mnx1:chodl-FLAG line. (****p < 0.0001;
statistical power = 1.00)
n.s., not significant; each data point represents
one animal; data are represented as mean ± SEM.
See also Figure S4.in inefficient escape from the stimulus. In (chodl/;
mnx1:chodl-FLAG) animals, this defect was fully rescued (Fig-
ures 3M and 3N), suggesting specificity of the phenotype for mo-
tor neurons. However, we cannot exclude a contribution from
chodl (http://zfin.org) and mnx1 (Korzh et al., 2011) co-express-
ing hindbrain neurons to the phenotype. In summary, a lack of
chodl impairs neuromuscular synaptogenesis, as well as axon
growth and branching, leading to specific aberrations in swim-
ming behavior.Characterization of Chodl Mutant Mice
To determine conserved functions of Chodl in mammals,
we analyzed a CRISPR-generated mouse mutant (see STAR
Methods). The mutant carries a 576-nucleotide deletion. This
removes exon 2, present in all known protein-coding isoforms
(Ensembl: Chodl-201 ENSMUST00000023568.13, Chodl-202
ENSMUST00000069148.12, Chodl-203 ENSMUST0000011
4216.1, and Chodl-205 ENSMUST00000232415.1; Figure S5A).
RT-PCR confirmed that Chodl exon 2 was not expressedCell Reports 29, 1082–1098, October 29, 2019 1087
(legend on next page)
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(Figure S5B).Chodl homozygous and heterozygousmutant mice
were viable, with no reduction in expected progeny for each ge-
notype (Figure S5C).
The removed exon 2 codes for most of the C-type lectin
domain, which is essential for the function of the protein (see
below). Moreover, removal of exon 2 induces a frameshift and
is predicted to produce a premature stop codon in all protein-
coding isoforms and, hence, mutant mice that lack Chodl
function.
Lack of Chodl Function Impairs Neurite Growth in
Cultured Mouse Motor Neurons
We investigated the neuronal function ofChodl by characterizing
neurite outgrowth of motor neurons (MNs) cultured from embry-
onic day 13.5 (E13.5) mouse spinal cord on Laminin. There was a
reduction in overall neurite length (by 31.87%) and number of
Tuj1-labeled neurite branches (by 23.39%) of Islet-1+ neurons
(Figures S5D–S5G). Cell body size was not altered (Figure S5H).
This may be due to a reduced intrinsic growth capacity of Chodl
mutant axons or interactions of Chodl with Laminin in vitro.
Synaptogenesis Is Impaired in Chodl Mutant Mice
The number of choline acetyltransferase (ChAT)-positive neu-
rons at spinal level L1–L2 in the ventral horn of 4-month-old
wild-type and Chodl mutant mice did not differ (Figures S6A–
S6C). Terminal branching of motor nerves, which does not coin-
cide with synaptogenesis at the branch points as in zebrafish,
was not affected in the mutant (Figures S6D and S6E), support-
ing that Chodl deficiency does not affect axon growth and
branching in vivo.
To assess synaptic phenotypes, we determined neuromus-
cular junction morphology by using immunohistochemistry.
The lumbrical muscles of 4-month-old mice were analyzed
because they are thin and flat enough to be mounted intact.
These muscles are innervated by Chodl+ ‘‘fast’’ motor neurons
(Enjin et al., 2010). The neuromuscular junctions were labeled
with a mix of antibodies to neurofilament (2H3; axons) and SV2
(pre-synapse) and fluorescently tagged a-bungarotoxin
(a-BTX; post-synapse).
The pre-synaptic area was increased by 41% in Chodlmutant
mice, the post-synaptic area by 28%, and the area of synapticFigure 4. Chodl Mutant Mice Show Morphological and Electrophysiolo
(A and B) Representative confocal micrographs of two wild-type (A) and two Ch
4-month-oldmice are shown. Neuronal tissue is labeled in green (2H3, neurofilame
(a-BTX, a-bungarotoxin).
(C and D) Both the pre-synaptic (C) and post-synaptic (D) areas are increased in C
post-synaptic area, *p = 0.0176).
(E and F) The areas of synaptic contact (E) and endplate (F) are also increased
*p = 0.0158; endplate area, **p = 0.0062).
(G) Chodl mutant mice have more fragmented post-synaptic endplates compare
(H) No differences are detected in occupancy (overlap percentage) of post-syna
(I) There is no significant difference in the 30 Hz decrement of CMAP between w
(J) No significant difference was observed in the 50Hz decrement of CMAP betw
(K and L) mEPP frequency (K) but not amplitude (L) differs between Chodl mutan
(M and N) Quantal content (M) and EPP amplitude (N) differ between the group
statistical power = 0.8044).
Each data point represents one animal. A total of 50–60 neuromuscular junctions
mean ± SEM. n.s., not significant. Scale bars, 30 mm.
See also Figures S5, S6, and S7.contact by 27%, compared to wild-type animals at 4 months
of age (Figures 4A–4E). The shape of synapses was changed,
as the area taken by individual synapses, the endplate area,
was increased by 30% (Figure 4F). Moreover, endplate labeling
in Chodl mutants was more fragmented, showing a fragmenta-
tion index (Jones et al., 2016) of 0.73, compared to 0.45 in
wild-type animals (Figure 4G).
To find indications of potential synapse degeneration, we
determined the proportion of post-synaptic sites that were not
occupied by pre-synaptic terminals. The percentage of inner-
vated post-synaptic area (‘‘overlap’’) was similar in 4-month-
old mutant and wild-type animals (Figure 4H), indicating that
there was no sign of neuromuscular junction denervation.
Hence, Chodlmutant mice show an enlargement of the synaptic
area that is similar to that seen in zebrafish embryos.
The Endplate Potential Amplitude Is Increased in the
Absence of Chodl in Mice
To test the function of neuromuscular synapses in Chodlmutant
mice, we measured the compound muscle action potential
(CMAP) in a phrenic-nerve-diaphragm-muscle preparation. The
phrenic nerve of wild-type, but not Chodl mutant animals con-
tains Chodl mRNA, as shown by RT-PCR (data not shown).
Measurements showed no failure of transmission up to 50-Hz
stimulation frequency in the mutant. The degree of CMAP decre-
ment at 10- (not shown), 30-, or 50-Hz stimulation frequency was
similar in mutants and wild-type littermate controls (Figures 4I
and 4J). In contrast, spontaneous miniature endplate potentials
(mEPPs) were increased by 40% in frequency (Figure 4K) but
were not altered in amplitude (Figure 4L) in the mutant compared
to wild-type animals. In addition, stimulated (1 Hz) EPPs were
increased in amplitude secondary to an increased quantal con-
tent (QC), defined as the calculated number of acetylcholine-
containing vesicles released per stimulation (Figures 4M and
4N). Labeling with antibodies to bassoon (Bssn), piccolo (Picc),
two very large scaffolding proteins of the cytomatrix assembled
at the active zone, and P/Q voltage-gated calcium channels
(VGCCs) (Gundelfinger et al., 2016), showed no detectable dif-
ferences in labeling intensity between Chodl mutants and wild-
type mice (Figures S6F–S6N). This suggests that the number of
available release sites is increased proportionally to the size ofgical Synaptic Defects of the Neuromuscular Junction
odl mutant (B) neuromuscular junctions on hind limb lumbrical muscles from
nt; SV2, synaptic vesicle protein 2), and post-synaptic AChRs are labeled in red
hodlmutant mice compared to wild-type mice (pre-synaptic area, *p = 0.0354;
in the Chodl mutant mice compared to wild-type mice (area of synaptic area,
d to wild-type mice at 4 months of age (**p = 0.0047).
ptic elements in Chodl mutant compared to wild-type mice.
ild-type and Chodl mutant mice.
een wild-type and Chodl mutant mice.
t and wild-type mice (*p = 0.0242; statistical power = 0.6313).
s (QC, **p = 0.0086; statistical power = 0.8138; EPP amplitude, **p = 0.0092;
are analyzed across 5 animals/genotype for (A)–(H). Data are represented as
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the enlarged synapse in Chodl mutants. However, we cannot
exclude a contribution by increased calcium sensitivity of release
sites to increased mEPP frequency and EPP amplitude/QC.
Taken together, these data indicate altered neurotransmission
at the neuromuscular junction in Chodl mutant mice.
Chodl Mutant Mice Show No Gross Alterations of Motor
Behavior
Weights of Chodl mutant mice were not systematically different
fromwild-type controls at 2, 3, and 4months of age (Figures S7A
and S7B). An assessment of general locomotor activity in an
open field environment revealed no differences in movement ac-
tivity (light beam breaks in open field) and thigmotaxis (the ten-
dency of mouse to remain close to the chamber lateral walls, a
measurement for anxiety) in mutants, compared to wild-type an-
imals (Figures S7C, S7D, and S7H). Motor coordination (acceler-
ating rotarod test) andmuscle strength (4-limb hanging wire test)
did also not reveal any changes (Figures S7E–S7G). Although
these tests did not detect changes inmotor behavior in theChodl
mutant, more subtle alterations cannot be excluded.
C-Type Lectin Domain and Intracellular Domain Are
Required to Mediate chodl Function
Because of the relative ease of phenotype analysis, we used the
zebrafish to study the mechanistic basis of chodl function. The
Chodl protein domain structure is typical of transmembrane
recognitionmolecules, with an extracellular C-type lectin domain
that may interact with extracellular binding partners, a trans-
membrane domain, and a short cytoplasmic tail with a number
of potential phosphorylation sites that may be involved in
intracellular signaling (Weng et al., 2002). To test for essential
functions of different domains, we generated FLAG-tagged con-
structsmissing either theC-type lectin domain or the intracellular
domain for transient experimental expression in motor neurons
of the chodl mutant, driven by the mnx1 regulatory sequences
(Figure 5A). Immuno-detection of the FLAG-tag indicated selec-
tive expression of constructs in motor neurons and their axons.
All constructs reached the cell surface in transfected HEK293T
cells (compare Figure 7A).
Only full-length Chodl showed rescuing activity in FLAG im-
muno-positive axons. FLAG-positive axons expressing full-
length Chodl were 31% longer than FLAG-negative axons in
the same embryos and 44.4% longer than axons in vector-in-
jected embryos. Removing either the C-type lectin domain or
intracellular domain resulted in no increase in axon length in
FLAG immuno-positive axons compared to controls (Figures
5B and 5C).Figure 5. C-Type Lectin Domain and Intracellular Domain Are Indispen
(A) A cartoon indicating the constructs used in (B) is shown.
(B) Photomicrographs show representative images of mosaic construct express
tochemistry (lateral trunk views): full-length (FL), chodl without the C-type lectin (w
shown.
(C) Only injection of the full-length chodl construct partially rescues axon length
(D) A cartoon indicating the potential phosphorylation sites of the intracellular do
(E) Lateral trunk views of mutant chodl zebrafish expressing full-length chodl and
(F) Experimental expression of wild-type, but not mutated chodl in motor neuron
Scale bars, 50 mm. Each data point represents one animal; data are representedTo determinewhether conformation and/or phosphorylation of
the intracellular domain was essential, we mutated 10 of the 11
identified potential phosphorylation sites by replacing serine
and threonine residues with alanine, leading to likely conforma-
tional changes and preventing phosphorylation of the intracel-
lular domain (Figure 5D). This construct did not show rescuing
activity of axon length, compared to the wild-type gene (Figures
5E and 5F). Hence, the C-type lectin domain and the intracellular
domain of chodl are functionally important.
chodl and col19a1 Show Genetic Interactions
The C-type lectin domain is likely to bind extracellular matrix
(ECM) components, which are concentrated at the horizontal
myoseptum (Schweitzer et al., 2005; Zhang et al., 2004), where
axons stall in zebrafish chodl mutants. Mutants in the muscle-
expressed col19a1 (zebrafish mutant name: stumpy) show
axon stalling at the horizontal myoseptum, as well as reduced
axon branching and enlarged post-synaptic sites at the adult
stage (Panzer et al., 2005). Because this phenotype is highly
reminiscent of that of chodl mutants, we determined potential
genetic interactions between chodl and col19a1. Using estab-
lished (Hilario et al., 2010; Zhong et al., 2012) morpholinos,
we found that injection of low concentrations of either morpho-
lino alone elicited no or only weak changes of motor axon
growth (Figures 6A and 6B). However, combining these mor-
pholinos at the same concentrations led to synergistic effects
on stalling of axons at the horizontal myoseptum. Of note, total
morpholino load was kept at the same level for all experiments
by adding non-specific control morpholino where appropriate.
This indicates a genetic interaction between chodl and
col19a1 (Figures 6C and 6D).
Chodl Is a Specific Binding Partner for ColXIXa1
To determine a potential physical interaction of Chodl and
ColXIXa1 proteins, we used co-immunoprecipitation. We tagged
Chodl with a FLAG tag at its C-terminal end (Chodl-FLAG).
ColXIXa1 was labeled with a hemagglutinin (HA) tag on either
the N-terminal (HA-ColXIXa1) or the C-terminal end (ColXIXa1-
HA) to control for possible interference of the tag with multimeri-
zation of the large protein (Figure 6E). Chodl-FLAG, purified from
transfected HEK293T cells, was incubated with the supernatant
of HA-ColXIXa1 and ColXIXa1-HA secreting HEK293T cells. An
immunoprecipitation assay shows that Chodl-FLAG co-immu-
noprecipitated both HA-ColXIXa1 and ColXIXa1-HA (Figure 6F).
Conversely, purified HA-ColXIXa1 and ColXIXa1-HA both pulled
downChodl-FLAG from cell lysates, indicating binding of the two
proteins (Figure 6G).sable for Chodl Function.
ion in motor axons of chodl mutant zebrafish, detected by FLAG immunohis-
ithout [w/o] CTLD), or intracellular domains (w/o intracellular domain [ID]), are
in FLAG+ motor axons (****p < 0.0001).
main that are mutated to alanine (with [w/] ID S/T / A) is shown.
mutated chodl are shown.
s partially rescues axonal length (****p < 0.0001; **p = 0.001).
as mean ± SEM; n.s., not significant; CTLD, C-type lectin domain.
Cell Reports 29, 1082–1098, October 29, 2019 1091
(legend on next page)
1092 Cell Reports 29, 1082–1098, October 29, 2019
As a control, we usedColXIIa1a in co-immunoprecipitation ex-
periments. Both ColXIIa1a and ColXIXa1 are Fibril-Associated
Collagens with Interrupted Triple Helices (FACIT) family colla-
gens (Bader et al., 2009; Hilario et al., 2010). ColXIIa1a is ex-
pressed in connective tissue and diffusely present at the nascent
horizontal myoseptum at 24 hpf (Bader et al., 2009). Purified Col-
XIIa1a-HA did not pull down Chodl-FLAG from cell lysates of
Chodl-FLAG overexpressing cells (Figure 6H), and purified
Chodl-FLAG did not pull down ColXIIa1a from the supernatant
of ColXIIa1a-HA transfected cells (Figure 6I). This indicates se-
lective physical binding of Chodl to ColXIXa1.
To determine the Chodl domains necessary for ColXIXa1 bind-
ing, we used truncated versions of Chodl, with either the intracel-
lular domain or the C-type lectin domain missing, for co-immu-
noprecipitation of full-length ColXIXa1-HA from supernatant
(Figure 6J). Chodl without the intracellular domain, but not the
version missing the C-type lectin domain, was still able to co-
immunoprecipitate ColXIXa1-HA (Figure 6K). Conversely, using
truncated versions of ColXIXa1, containing only the collagenous
domains or only the thrombospondin domain (Figures 6L), we
showed that only the truncated protein with the collagenous do-
mains was able to co-immunoprecipitate Chodl-FLAG from
lysates of overexpressing cells (Figures 6M and 6N). This sup-
ports a scenario in which the trans-membrane protein Chodl
binds the collagenous repeats of ColXIXa1 at the cell surface
by its extracellular C-type lectin domain.
Chodl Binds ColXIXa1 at the Cell Surface
To observe interactions of native Chodl and ColXIXa1 in intact
cells, we incubated HEK293T cells that overexpress Chodl-
FLAG with culture media containing ColXIXa1-HA for 24 h.
Measuring immuno-fluorescence intensity across optical sec-
tions through fixed cells showed highest Chodl-FLAG immuno-
reactivity at the cells’ edges (Figures 7A and 7B), consistent
with trans-membrane localization. ColXIXa1-HA immunoreac-
tivity on the cells was strong and located at the cell surface (Fig-
ures 7A and 7B). Incubating Chodl-FLAG overexpressing cellsFigure 6. chodl and collagen19a1 Show Genetic Interaction and Prote
(A–C) Sub-threshold application of both chodl (A; 0.25 mM) and col19a1 (B; 0.5 m
aberrant motor axon growth. Combining the two active morpholinos at the same
(D) Quantification of stalled axons (chodlmorpholino + col19a1morpholino synerg
values, ****p < 0.0001). Each data point represents one animal; data are represe
(E) Graphic presentations of the fusion proteins used in in vitro binding assays are
domain; FLAG, FLAG tag (DYKDDDDK); TSPN, thrombospondin N-terminal-like d
fibronectin type III domain; VWFA, von Willebrand factor type A domain.
(J) Graphic presentations of the fusion proteins used in in vitro binding assays ar
(L) A cartoon of the fusion proteins used in in vitro binding assays is shown.
(F) Purified FLAG-tagged chondrolectin binds HA-tagged CollagenXIXa1. As neg
experiments, n = 2 (HA-ColXIXa1, FLAG immunoprecipitation [IP]), n = 4 (ColXIX
(G) HA-tagged CollagenXIXa1 interacts with FLAG-tagged chondrolectin. Empty
experiments, n = 5 (Chodl-FLAG, HA IP).
(H) ColXIIa1 does not interact with FLAG-tagged Chodl. Number of independent
(I) Purified chondrolectin does not pull down HA-tagged ColXIIa1. Empty HA-m
ments, n = 2.
(K) FLAG-tagged chondrolectin without the intracellular domain (chodl w/o ID),
ColXIXa1 from culture media. Number of independent experiments, n = 4.
(M) The thrombospondin domain of ColXIXa1 (HA-TSPN) does not immuno-prec
HA IP).
(N) The collagenous repeats domain (HA-NC-Col) of ColXIXa1 immuno-precipitatewith ColXIIa1a-HA as a control showed only minimal fluores-
cence that did not coincide with Chodl-FLAG at the cell surface
(Figures 7A and 7B). Likewise, cells transfected with membrane-
bound EGFP as a control did not bind ColXIXa1-HA from theme-
dium (Figures 7A and 7B). Expression of a construct missing the
intracellular domain of Chodl still bound ColXIXa1 at the plasma
membrane (Figures 7A and 7B). In contrast, the construct
missing the C-type lectin domain of Chodl, which was still
targeted to themembrane, did not localize ColXIXa1 from the su-
pernatant to the cell membrane (Figures 7A and 7B). This indi-
cates that native Chodl is a transmembrane protein that binds
extracellular ColXIXa1 with its C-type lectin domain.
In the absence of specific antibodies to Chodl and ColXIXa1, it
is not possible to determine whether the proteins co-localize
in vivo. However, in the zebrafish rescue line (chodl/;
mnx1:chodl-FLAG), in which axons deficient in endogenous
chodl grow beyond the horizontal myoseptum with the support
of experimentally expressed chodl, we observed the Chodl-
FLAG protein in a punctate pattern along the axon, in close
apposition with AChR+ post-synaptic clusters (Figure 7C). This
is consistent with a pre-synaptic function of Chodl.
In summary, our results indicate that Chodl on motor axons
mediates essential interactions with ColXIXa1 in the muscle
ECM. Without these interactions, synapses fail to form correctly
and synapse-dependent axon growth and branching, as well as
motor behaviors, are impaired (graphically summarized in
Figure 7D).
DISCUSSION
Chodl Acts Primarily in Synaptogenesis
The increase in synaptic area at the horizontal myoseptum in ze-
brafish and lumbrical muscle of mouse Chodl mutants indicates
an evolutionarily conserved role of the transmembrane molecule
in synaptogenesis.
All observed in vivo phenotypes are potential consequences of
defective synaptogenesis, supporting the notion of synapse-in Binding
M) morpholinos (MOs) together with control morpholino (CoMO) do not induce
concentrations leads to axon stalling (C).
y versus hypothetical mean of chodlmorpholino added to col19a1morpholino
nted as mean ± SEM.
shown. SP, signal peptide; CTLD, C-type lectin domain; TMD, transmembrane
omain; Col, collagenous domain; HA, human influenza hemagglutinin tag; FN3,
e shown.
ative control, FLAG-empty magnetic beads are used. Number of independent
a1-HA, FLAG IP).
HA-magnetic beads are used as negative controls. Number of independent
experiments, m = 2.
agnetic beads are used as negative controls. Number of independent exprei-
but not without the C-type lectin domain (w/o CTLD), precipitates HA-tagged
ipitates Chodl-FLAG. Number of independent experiments, n = 2 (HA-TSPN,
s Chodl-FLAG. Number of independent experiments, n = 4 (HA-NC-Col, HA IP).
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dependentmotor axon growth in zebrafish. The phenotype of the
CaP axon is prolonged stalling at the horizontal myoseptum. The
horizontal myoseptum is a choice region in which the axons of
the three primary motor neurons stall to integrate their
pathway-specific cues (Beattie et al., 2002; Myers et al., 1986;
Westerfield et al., 1986). However, the horizontal myoseptum is
also a major synaptic site (Panzer et al., 2005; Panzer et al.,
2006), and we show that in chodl mutants, synaptogenesis at
this site is defective. Hence, formation of the nascent synapse
might be a prerequisite for elongation of motor axons beyond
the en passant synaptic site at the horizontal myoseptum.
Indeed, naturally occurring pausing of CaP growth cones at
the horizontal myoseptum might be due to the time required to
form en passant synapses with muscle pioneers before growth
can proceed (Eisen et al., 1986; Zhong et al., 2012), as in other
systems (Hatada et al., 1999).
The idea that impaired synapse formation is what keeps the
axon from growing in the chodl mutant is supported by our
observation that filopodial dynamics is unperturbed. Filopodia
extension has previously been identified as integral part of
growth cone advance (Flanagan-Steet et al., 2005; Panzer
et al., 2006). Moreover, in a previous time-lapse study, we
have shown that when chodl expression is prevented, the speed
of motor growth cone advance is unimpaired above and below
the horizontal myoseptum site, suggesting that chodl-deficient
axons are, in principle, capable of unimpaired growth (Zhong
et al., 2012).
In 3-day-old mutant zebrafish, axon branching onto the mus-
cle is strongly reduced. Motor axon branching has been sug-
gested to depend on proper synaptogenesis in Xenopus larvae
(Javaherian and Cline, 2005), in which new branches of motor
axons always originate at a synaptic site. Our analysis of the
branching pattern of motor axons in zebrafish larvae also shows
that almost all axon branches onto themusculature occur at syn-
apses. Synapse-dependent axon branching is also observed in
the optic projection of Xenopus (Alsina et al., 2001) and zebrafish
(Meyer and Smith, 2006), aswell as in the thalamocortical projec-
tion in mammals (Matsumoto et al., 2016).
Mouse motor axons, which do not form en passant synapses
during growth or branching at synaptic sites but mainly form ter-
minal synapses instead (Sanes and Lichtman, 1999), did not
show any obvious signs of reduced axon growth or branching
in Chodl mutants. Hence, a lack of Chodl only affects synapto-
genesis in vivo. However, in vitro, motor axons of Chodl mutant
mice show reduced neurite growth, revealing a potential contri-
bution of Chodl to axon growth that is compensated for in vivo.Figure 7. Experimentally Expressed Chodl Binds Extracellular ColXIXa
(A and B) In transfected HEK cells, full-length constructs (Chodl-FLAG) and those
FLAG – CTLD) show high plasma membrane labeling. Chodl-FLAG and Chodl-FL
surface. Cells transfected with membrane-bound EGFP (control) did not bind Co
surement trajectories used to generate intensity profiles in (B). Number of individ
(C) A lateral view of a motor axon that has grown beyond the horizontal myoseptum
hpf is shown. Experimentally expressed Chodl-FLAG is present in the cytoplas
(AChR immunohistochemistry) at the horizontal myoseptum.
(D) Schematic summary of results is shown. Axonal Chodl is necessary to restric
spinal cord; CaP MN, caudal primary neuron; NC, notochord; HM, horizontal myo
C-type lectin domain; TMD, transmembrane domain.
Scale bar in (C): 20 mm; scale bars in (A): 10 mm.The behavioral phenotype in zebrafish chodl mutants
(reduced turn angle in escape response) is a likely conse-
quence of hypo-innervation of the muscle tissue due to
impaired synapse-dependent motor axon branching. In mice,
we could not detect changes in CMAP or behavioral conse-
quences of Chodl deficiency. However, the presence of
anatomical and physiological phenotypes in Chodl mutant
mice suggests that more sensitive tests might reveal deficits.
Taken together, the above observations suggest an essential
function of Chodl at the neuromuscular junction. Interestingly,
Chodl- (Zeng and Sanes, 2017) and Col19a1-expressing neu-
rons also exist in the cortex, and Col19a1 mutant mice show
synaptic defects (Su et al., 2016). This opens the perspective
of more widespread roles of this ligand/receptor pair in synap-
togenesis in other CNS regions.
ColXIXa1 Is a Binding Partner for Chodl
Immuno-precipitations show that the C-type lectin domain of
Chodl binds the collagenous domains of ColXIXa1 but does
not bind ColXIIa1a. However, other collagens could also act as
a ligand, such as ColXV, which possesses collagenous domains
(Eklund et al., 2000) and for which the mutant phenotype is also
similar to that of chodlmutants in zebrafish (Guillon et al., 2016).
Cell transfection assays indicate that binding of extracellular
ColXIXa1 by the extracellular C-type lectin domains of Chodl oc-
curs at the plasma membrane. This is consistent with known
roles of the C-type lectin domain in recognition proteins of im-
mune cells (Chiffoleau, 2018).
The horizontal myoseptum in zebrafish is rich in ECM factors,
such as Tenascin-C (Schweitzer et al., 2005), Chondroitin sul-
fates (Zhang et al., 2004), and collagens (Guillon et al., 2016),
which are likely to take part in synaptogenesis. The fact that
ColXIXa1 is produced by muscle cells (Hilario et al., 2010) and
Chodl by motor neurons (Zhong et al., 2012) makes it probable
that these factors interact at the horizontal myoseptum synap-
ses. This is supported by the observation that the col19a1
mutant phenotype also entails prolonged stalling in this exact
location (Beattie et al., 2000) and that knocking down col19a1
and chodl leads to a synergistic increase in stalling specifically
at the horizontal myoseptum, as we show here. Moreover, in
functional rescue experiments, we find tagged Chodl along the
motor axons, including the horizontal myoseptum region, indi-
cating that functional Chodl is present at the horizontal myosep-
tum in motor axons. Specific antibodies to ColXIXa1 and Chodl,
which are currently unavailable, would be needed to directly
show interactions of endogenous proteins in vivo.1 at the Cell Surface and Is Targeted to Motor Axons.
without intracellular domain (Chodl-FLAG – ID) or C-type lectin domain (Chodl-
AG – ID bind ColXIXa1, but not ColXIIa1 (control), from supernatant at the cell
lXIXa1. Single optical sections are shown in (A) and arrows indicate the mea-
ual experiments, 2.
(HM) in a (mnx1:EGFP; chodl/;mnx1:chodl-FLAG) zebrafish embryo at 28
m and punctate clusters along the axon (EGFP), overlaying the synapse area
t the size of the neuromuscular junction by binding extracellular ColXIXa1. SC,
septum; TSPN, thrombospondin domain; NC-Col, collagenous repeats; CTLD,
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Functional rescue experiments show that both the C-type lec-
tin domain and intracellular domain are essential for Chodl func-
tion in vivo. Overall, this suggest a scenario in which axonal
Chodl needs to bind muscle-derived ColXIXa1 to form proper
synapses with muscle pioneers. ColXIXa1 binding likely leads
to signaling events. This may involve binding of the intracellular
domain to other proteins and/or changes in phosphorylation of
the intracellular domain. The Chodl intracellular domain interacts
with the Rab geranylgeranyl transferase b subunit in vitro (Claes-
sens et al., 2008), but there are likely more interactions.
Connection of Chodl to SMA
Synapse destabilization is an early event in SMA disease pro-
gression (McGovern et al., 2008), and Chodl is dysregulated
early in a mouse model of SMA (Bäumer et al., 2009; Zhang
et al., 2008). With its role in synaptic development, dysregulation
of Chodl may contribute to synaptic phenotypes in the disease.
Indeed, overexpression of chodl partially rescues CaP axon
growth defects in an SMA model in zebrafish (Sleigh et al.,
2014a), supporting the hypothesis that dysregulation of chodl
may be one of the disease mechanisms.
Of note, the rescue was only partial, and aberrations in CaP
axon growth are more severe in SMA models than those seen
in the chodl mutant here (Hao et al., 2013; McWhorter et al.,
2003). Moreover, mouse SMA models show synaptic degenera-
tion and motor neuron loss (Groen et al., 2018; Wishart et al.,
2010), which we did not observe for the mouse Chodl mutant.
It is, therefore, likely that dysregulation of other proteins in
addition to chodl causes the phenotype in SMA models and
the disease. Nevertheless, a lack of chodl replicates some syn-
aptic defects seen in SMA models in zebrafish (Boon et al.,
2009) and mice (Mentis et al., 2011), supporting that its dysregu-
lation contributes to the disease phenotype. Interestingly, aber-
rant chodl expression has also been observed in a mouse ALS
model (Wootz et al., 2010), and higher tissue levels of its binding
partner COL19A1 are associated with faster disease progression
in patients (Calvo et al., 2019).
Why is aberrant growth of motor axons in zebrafish a sensitive
indicator of SMA- (Giacomotto et al., 2015; Oprea et al., 2008)
and ALS- (Kabashi et al., 2011; Van Hoecke et al., 2012) related
manipulations in vivo? In mouse models of motor neuron dis-
eases, aberrant axon growth is rare, but aberrations of synapse
formation are observed, as well as a later loss of motor neurons
(McGovern et al., 2008; Mentis et al., 2011). One possible expla-
nation is that axon growth in zebrafish, but not mice, is synapse
dependent. Hence, aberrant motor axon growth in zebrafish
SMA and other motor neuron disease models (Thomas-Jinu
et al., 2017) might be a consequence of impaired expression of
genes involved in synaptogenesis or synapse stabilization,
such as chodl. However, other affected cellular mechanisms
(Boyd et al., 2017; Donlin-Asp et al., 2016; Groen and
Gillingwater, 2015) may also cause axonal aberrations in
zebrafish.
In conclusion, we describe a new ligand receptor interaction
between the survival motor neuron (SMN) downstream gene
Chodl andColXIXa1 that is necessary for the formation of neuro-
muscular junctions and subsequent motor axon growth and
branching in zebrafish.1096 Cell Reports 29, 1082–1098, October 29, 2019STAR+METHODS
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Oprea, G.E., Kröber, S., McWhorter, M.L., Rossoll, W., M€uller, S., Krawczak,
M., Bassell, G.J., Beattie, C.E., and Wirth, B. (2008). Plastin 3 is a protective
modifier of autosomal recessive spinal muscular atrophy. Science 320,
524–527.
Panzer, J.A., Gibbs, S.M., Dosch, R., Wagner, D., Mullins, M.C., Granato, M.,
and Balice-Gordon, R.J. (2005). Neuromuscular synaptogenesis in wild-type
and mutant zebrafish. Dev. Biol. 285, 340–357.
Panzer, J.A., Song, Y., and Balice-Gordon, R.J. (2006). In vivo imaging of pref-
erential motor axon outgrowth to and synaptogenesis at prepatterned acetyl-
choline receptor clusters in embryonic zebrafish skeletal muscle. J. Neurosci.
26, 934–947.
Ran, F.A., Hsu, P.D.,Wright, J., Agarwala, V., Scott, D.A., and Zhang, F. (2013).
Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281–
2308.
Riedl, J., Crevenna, A.H., Kessenbrock, K., Yu, J.H., Neukirchen, D., Bista, M.,
Bradke, F., Jenne, D., Holak, T.A., Werb, Z., et al. (2008). Lifeact: a versatile
marker to visualize F-actin. Nat. Methods 5, 605–607.
Rishal, I., Golani, O., Rajman, M., Costa, B., Ben-Yaakov, K., Schoenmann, Z.,
Yaron, A., Basri, R., Fainzilber, M., and Galun, M. (2013). WIS-NeuroMath en-
ables versatile high throughput analyses of neuronal processes. Dev. Neuro-
biol. 73, 247–256.
Sanes, J.R., and Lichtman, J.W. (1999). Development of the vertebrate neuro-
muscular junction. Annu. Rev. Neurosci. 22, 389–442.
Schneider, C.A., Rasband, W.S., and Eliceiri, K.W. (2012). NIH Image to
ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675.
Schweitzer, J., Becker, T., Lefebvre, J., Granato, M., Schachner, M., and
Becker, C.G. (2005). Tenascin-C is involved in motor axon outgrowth in the
trunk of developing zebrafish. Dev. Dyn. 234, 550–566.1098 Cell Reports 29, 1082–1098, October 29, 2019Sleigh, J.N., Barreiro-Iglesias, A., Oliver, P.L., Biba, A., Becker, T., Davies,
K.E., Becker, C.G., and Talbot, K. (2014a). Chondrolectin affects cell survival
and neuronal outgrowth in in vitro and in vivo models of spinal muscular atro-
phy. Hum. Mol. Genet. 23, 855–869.
Sleigh, J.N., Burgess, R.W., Gillingwater, T.H., and Cader, M.Z. (2014b).
Morphological analysis of neuromuscular junction development and degener-
ation in rodent lumbrical muscles. J. Neurosci. Methods 227, 159–165.
Su, J., Chen, J., Lippold, K., Monavarfeshani, A., Carrillo, G.L., Jenkins, R., and
Fox, M.A. (2016). Collagen-derived matricryptins promote inhibitory nerve ter-
minal formation in the developing neocortex. J. Cell Biol. 212, 721–736.
Thomas-Jinu, S., Gordon, P.M., Fielding, T., Taylor, R., Smith, B.N., Snowden,
V., Blanc, E., Vance, C., Topp, S., Wong, C.H., et al. (2017). Non-nuclear Pool
of Splicing Factor SFPQ Regulates Axonal Transcripts Required for Normal
Motor Development. Neuron 94, 322–336.e5.
Van Hoecke, A., Schoonaert, L., Lemmens, R., Timmers, M., Staats, K.A.,
Laird, A.S., Peeters, E., Philips, T., Goris, A., Dubois, B., et al. (2012). EPHA4
is a disease modifier of amyotrophic lateral sclerosis in animal models and in
humans. Nat. Med. 18, 1418–1422.
Webster, R.G., Cossins, J., Lashley, D., Maxwell, S., Liu, W.W., Wickens, J.R.,
Martinez-Martinez, P., de Baets, M., and Beeson, D. (2013). A mouse model of
the slow channel myasthenic syndrome: Neuromuscular physiology and ef-
fects of ephedrine treatment. Exp. Neurol. 248, 286–298.
Wehner, D., Tsarouchas, T.M., Michael, A., Haase, C., Weidinger, G., Reimer,
M.M., Becker, T., and Becker, C.G. (2017). Wnt signaling controls pro-regen-
erative Collagen XII in functional spinal cord regeneration in zebrafish. Nat.
Commun. 8, 126.
Wen, H., Linhoff, M.W., McGinley, M.J., Li, G.L., Corson, G.M., Mandel, G.,
and Brehm, P. (2010). Distinct roles for two synaptotagmin isoforms in syn-
chronous and asynchronous transmitter release at zebrafish neuromuscular
junction. Proc. Natl. Acad. Sci. USA 107, 13906–13911.
Weng, L., Smits, P., Wauters, J., and Merregaert, J. (2002). Molecular cloning
and characterization of human chondrolectin, a novel type I transmembrane
protein homologous to C-type lectins. Genomics 80, 62–70.
Westerfield, M. (2000). The Zebrafish Book: a Guide for the Laboratory Use of
Zebrafish (Danio rerio), Fourth Edition (University of Oregon Press).
Westerfield, M., McMurray, J.V., and Eisen, J.S. (1986). Identified motoneu-
rons and their innervation of axial muscles in the zebrafish. J. Neurosci. 6,
2267–2277.
Wiese, S., Herrmann, T., Drepper, C., Jablonka, S., Funk, N., Klausmeyer, A.,
Rogers, M.L., Rush, R., and Sendtner, M. (2010). Isolation and enrichment of
embryonic mouse motoneurons from the lumbar spinal cord of individual
mouse embryos. Nat. Protoc. 5, 31–38.
Wishart, T.M., Huang, J.P., Murray, L.M., Lamont, D.J., Mutsaers, C.A., Ross,
J., Geldsetzer, P., Ansorge, O., Talbot, K., Parson, S.H., and Gillingwater, T.H.
(2010). SMN deficiency disrupts brain development in a mouse model of se-
vere spinal muscular atrophy. Hum. Mol. Genet. 19, 4216–4228.
Wootz, H., Enjin, A., Wallén-Mackenzie, A., Lindholm, D., and Kullander, K.
(2010). Reduced VGLUT2 expression increases motor neuron viability in
Sod1(G93A) mice. Neurobiol. Dis. 37, 58–66.
Zeng, H., and Sanes, J.R. (2017). Neuronal cell-type classification: challenges,
opportunities and the path forward. Nat. Rev. Neurosci. 18, 530–546.
Zhang, J., Lefebvre, J.L., Zhao, S., and Granato, M. (2004). Zebrafish un-
plugged reveals a role for muscle-specific kinase homologs in axonal pathway
choice. Nat. Neurosci. 7, 1303–1309.
Zhang, Z., Lotti, F., Dittmar, K., Younis, I., Wan, L., Kasim, M., and Dreyfuss, G.
(2008). SMN deficiency causes tissue-specific perturbations in the repertoire
of snRNAs and widespread defects in splicing. Cell 133, 585–600.
Zhong, Z., Ohnmacht, J., Reimer, M.M., Bach, I., Becker, T., and Becker, C.G.
(2012). Chondrolectin mediates growth cone interactions of motor axons with
an intermediate target. J. Neurosci. 32, 4426–4439.
STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit anti-Tuj1 Covance N/A
Mouse anti-Islet1 DSHB Cat# 40.2D6; RRID:AB_528315
Mouse anti- 2H3, neurofilament (NF-M) DSHB 2H3; RRID:AB_531793
Mouse anti-bassoon, clone name- SAP7F407 BioScience, Nottingham Cat# GTX13249; RRID:AB_422275
Rabbit anti-piccolo Synaptic Systems, Germany Cat# 142002; RRID:AB_887759
Rabbit anti-P/Q-VGCC (Cav2.1) Synaptic Systems, Germany Cat# 152203; RRID:AB_2619841
Anti-p75 NGF Receptor antibody [MLR2] Abcam Cat# ab61425; RRID:AB_943967
Chicken anti-GFP Abcam Cat# AB13970; RRID:AB_300798
Mouse anti- SV2, Synaptic vesicle glycoprotein 2A DSHB SV2; RRID:AB_2315387
Mouse anti-Znp-1 DSHB Znp1; RRID:AB_531910
Rat anti-AChR DSHB mAb35; RRID:AB_528405
Rabbit anti-FLAG Cell Signaling Technology Cat# 14793; RRID:AB_2572291
Mouse anti-FLAG Sigma-Aldrich Cat# F1804; RRID:AB_262044
Mouse anti-HA BioLegend Cat# 901501; RRID:AB_2565006
Alexa Fluor 488 anti-phalloidin ThermoFisher Scientific Cat# A12380
Tetramethylrhodamine (TRITC) a-BTX- 568 Cambridge Bioscience Cat# BT00012
Alexa Fluor  488 Donkey anti-mouse ThermoFisher Scientific Cat# A21202; RRID:AB_141607
Alexa Fluor  488 Donkey anti-rabbit ThermoFisher Scientific Cat# A21206; RRID:AB_2535792
Alexa Fluor  488 Goat-anti rabbit ThermoFisher Scientific Cat# A27034; RRID:AB_2536097
Alexa Fluor  568 Goat-anti rabbit ThermoFisher Scientific Cat# A11011; RRID:AB_143157
Alexa Fluor  488 Goat anti-mouse ThermoFisher Scientific Cat# A28175; RRID:AB_2536161
Alexa Fluor  488 AffiniPure Donkey
Anti-Chicken IgY (IgG) (H+L)
Jackson ImmunoResearch Cat# 703-545-155; RRID:AB_2340375
Alexa Fluor 594 AffiniPure Donkey
Anti-Mouse IgG (H+L)
Jackson ImmunoResearch Cat# 715-585-150; RRID:AB_2340854
Alexa Fluor 594 AffiniPure Donkey
Anti-Mouse IgG (H+L) (Minimally cross-
reactive to Rat, pre-adsorbed)
Jackson ImmunoResearch Cat# 715-585-151; RRID:AB_2340855
Alexa Fluor 488 AffiniPure Donkey Anti-Rat
IgG (H+L) (minimally cross-reactive to
Mouse, pre-adsorbed)
Jackson ImmunoResearch Cat# 712-545-153; RRID:AB_2340684
Alexa Fluor 647 AffiniPure Donkey Anti-Rat
IgG (H+L) (Minimally cross-reactive to
Mouse, pre-adsorbed)
Jackson ImmunoResearch Cat# 712-605-153; RRID:AB_2340694
Alexa Fluor 647 AffiniPure Donkey
Anti-Rabbit IgG (H+L)
Jackson ImmunoResearch Cat# 711-605-152; RRID:AB_2492288
Alexa Fluor 488 AffiniPure Donkey
Anti-Mouse IgG (H+L)
Jackson ImmunoResearch Cat# 715-545-150; RRID:AB_2340846
Alexa Fluor 647 AffiniPure Donkey
Anti-Mouse IgG (H+L)
Jackson ImmunoResearch Cat# 715-605-150; RRID:AB_2340862
IRDye 800CW Goat anti-Mouse IgG (H + L)
Highly Cross-Adsorbed
Li-Cor Cat# 925-32210; RRID:AB_2687825
IRDye 680LT Goat anti-Rabbit IgG (H + L)
Highly Cross-Adsorbed
Li-Cor Cat# 925-68021; RRID:AB_2713919
FLAG M2 magnetic beads Sigma-Aldrich Cat# M8823; RRID:AB_2637089
HA magnetic beads ThermoFisher Scientific Cat# 88836; RRID:AB_2749815
(Continued on next page)
Cell Reports 29, 1082–1098.e1–e10, October 29, 2019 e1
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Chemicals, Peptides, and Recombinant Proteins
Poly-DL-ornithine hydrobromide Sigma Cat# P8638
Recombinant Human CNTF Peprotech Cat# 450-13
Recombinant Human/Murine/Rat BDNF Peprotech Cat# 450-02
Recombinant Human GDNF Peprotech Cat# 450-10
Recombinant Human NT-3 Peprotech Cat# 450-03
u-Conotoxin GIIIB Peptide Institute Cat# 4217v
Poly-D-Lysine solution, 1.0 mg/ml Merck Millipore Corporation Cat# A-003-E
Critical Commercial Assays
PureLink Genomic DNA Kit Thermo Fisher Scientific Cat# K182001
Lipofectamine 2000 Transfection Reagent ThermoFisher Scientific Cat# 11668030
mMessage mMachine T7 Transcription kit ThermoFisher Scientific Cat# AM1344
mirVana miRNA kit ThermoFisher Scientific Cat# AM1560
mMessage mMachine T3 Transcription kit ThermoFisher Scientific Cat# AM1348
RNeasy Mini Kit QIAGEN Cat# 74106
iScript cDNA Synthesis Kit Bio-Rad Cat# 170-8891
SsoAdvanced Universal SYBR Green Supermix Bio-Rad Cat# 1725271
Deposited Data
File containing the original western blotting images Mendeley Data https://doi.org/10.17632/g23ts8jjpp.1
File containing the Coomassie gels Mendeley Data https://doi.org/10.17632/g23ts8jjpp.1
Experimental Models: Cell Lines
HEK293T cells Culture Collections Public Health
England Porton Down, Salisbury, UK
N/A
Experimental Models: Organisms/Strains
Chodl em1(IMPC)H - C57BL/6NTac background https://www.mousephenotype.org/ https://www.infrafrontier.eu/




Tg (mnx1:GFP) Flanagan-Steet et al., 2005 N/A
chodl /; mnx1:GFP This paper N/A
chodl/; mnx1:chodl-FLAG This paper N/A
Oligonucleotides
Mouse Chodl genotyping Pair A, Forward:50- AC
GTGAGTTTAGAGGGAAAGTTTG 30
This paper N/A
Mouse Chodl genotyping Pair A, Reverse: 50- CA
GGATTGGCAGTTGGTTGGT 30
This paper N/A
Mouse Chodl genotyping Pair B, Forward: 50-GGC
TGGCTTGTGAAAGTGAAG-30
This paper N/A






gRNA targeting sequence zf chodl (exon 1) Forward:
50 -TAGGAGGATGCGCGCGACACTC - 30
This paper N/A
gRNA targeting sequence zf chodl (exon 1) Reverse:
50 - AAACGAGTGTCGCGCGCATCCT – 30
This paper N/A
Zf chodl genotyping Forward: 50 – GACTGGAGCAA
GTCTGTG – 30
This paper N/A
Zf chodl genotyping Reverse: 50 – CTGCACGAGAC
CAGAAAA – 30
This paper N/A
Primers for chodl mutagenesis, see Table S1 This paper N/A
(Continued on next page)
e2 Cell Reports 29, 1082–1098.e1–e10, October 29, 2019
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Primers for detecting chodl and beta-actin mRNA,
see Table S2
This paper N/A
Primers for generating the plasmids used in this
paper, see Table S3
This paper N/A
Recombinant DNA
pCMV-MCS Susanne Schoch, University
of Bonn, Germany
N/A
pDISPLAY Aydin et al., 2012 N/A
pminiTol2 Balciunas et al., 2006 Addgene Plasmid #31829
pT3TS-Tol2 Balciunas et al., 2006 Addgene Plasmid #31831
gRNA scaffold vector pT7-gRNA Jao et al., 2013 Addgene Plasmid #46759
pCS2-nCas9n Wenbio Chen Addgene Plasmid #47929
pCS2P+ Marc Kirschner Addgene Plasmid #17095
pCS-ColXIXeGFP-DEST Hilario et al., 2010 N/A
hsp70l:col12a1a-p2A-cerulean Wehner et al., 2017 N/A
Software and Algorithms
ImageJ Schneider et al., 2012 https://imagej.nih.gov/ij/
GraphPad Prism 8.1.2 GraphPad Software Company https://www.graphpad.com/scientific-
software/prism/
WIS-NeuroMath software Rishal et al., 2013 https://biii.eu/wis-neuromath
NMJ-morph Jones et al., 2016 https://datashare.is.ed.ac.uk/handle/
10283/2113
pClamp 10 Molecular Devices https://moleculardevices.box.com/s/
l8h8odzbdikalbje1iwj85x88004f588





ZenBlue2.3 software, Zeiss Carl Zeiss Company https://www.zeiss.com/microscopy/int/
home.html?vaURL=www.zeiss.com/
microscopy
Odyssey Fc Imaging system and Image
Studio Lite (v. 5.2)
Li-Cor Corporate Company https://www.licor.com/bio/image-
studio-lite/





G*Power 3.1 Faul et al., 2009 https://gpower.software.informer.com/3.1/
LightCycler 96 Instrument Software Version
1.1.1 (Roche)




Vivaspin 20-50000 MWCO GE Healthcare Cat# 28-9323-62LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and request for resources should be directed to andwill be fulfilled by the LeadContact, ThomasBecker (thomas.
becker@ed.ac.uk). This study did not generate new unique reagents.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Sources of zebrafish, mouse models, and cell culture used in this study are reported below and in the Key Resources Table.Cell Reports 29, 1082–1098.e1–e10, October 29, 2019 e3
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All fish were kept and bred in our laboratory fish facility according to standard procedures (Westerfield, 2000), and all experiments
have been approved by the British Home Office (project license no.: 70/8805). Fish lines used were the WIK wild-type strain of
zebrafish and the Tg (mnx1:GFP) (previously HB9:GFP) (Flanagan-Steet et al., 2005) transgenic line. Further transgenic lines and
mutants were generated using CRISPR/Cas9 and Tol2 transgenesis as described below. These lines are chodl/, and
chodl/;mnx1:chodl-FLAG.
Mouse
The Chodl mutant mouse was generated as part of the IMPC project (https://www.mousephenotype.org/), designated
Chodlem1(IMPC)H, and maintained on a C57BL/6NTac background. All mouse experiments were carried out under UK Home Office
project license no. PDFEDC6F0. For ex vivo electrophysiology experiments, 4 control (2 males and 2 females) and 6 Chodl mutant
(3 males and 3 females) mice were used. For primary motor neuron culture, 3 control (2 males and 1 female) and 3 Chodl mutant
(2 males and 1 female) mice were used.
Cell culture
HEK293T cells were used in this study for biochemical assays. Cells were cultured in DMEM medium supplemented with 10% fetal
bovine serum (FBS), 1X Penicillin-Streptomycin (Life Technologies) at 37C and 5% CO2 levels.
METHOD DETAILS
Plasmids for zebrafish
To generate the plasmids used in various experimental procedures the following vectors were used mammalian expression vectors
pCMV-MCS, kindly provided by Susanne Schoch-McGovern, Bonn, Germany; pDISPLAY, kindly provided by Jeffrey Lee, Toronto,
Canada (Aydin et al., 2012); pminiTol2, a gift from Stephen Ekker, Addgene plasmid # 31829 (Balciunas et al., 2006); gRNA scaffold
vector pT7-gRNA, agift fromWenbiao Chen, Addgene plasmid # 46759 ;and pCS2P, a gift fromMarc Kirschner, Addgene # 17095. All
restriction enzymes and buffers used were from New England Biolabs. A full list of primers is provided in Table S3 and S1.
The zebrafish full-length chondrolectin (chodl) was obtain by PCR using pCS2-chodl-myc as template (forward EcoRI 50- GCG
GAA TTC AAC ATG CGC GCG ACA CTC AGG - 30and reverse XhoI-FLAG 50- GCG CTC GAG TCA TTT ATC ATC ATC ATC TTT
ATA ATC TGG TCC TGG GAC CTC CAT GCC ACT GTC - 30) and subcloned into the EcoRI-XhoI-digested CMV-MCS vector
(pCMV-chodl-FLAG). Generation of truncated versions was achieved by PCR using the same forward primer as for full-length chodl
and two different reverse primers (XhoI-FLAG 50- GCGCTCGAGTCA TTT ATCATCATCATC TTT ATA ATC TGGTCCTGGCAACAT
CTG GAA ACA GCA CG-30 and XbaI –FLAG 50-GCG TCT AGA TCA TTT ATC ATC ATC ATC TTT ATA ATC TGG TCC TGG GAC CTC
CAT GCC ACT GTC-30). PCR fragments were ligated into CMV-MCS vector digested with EcoRI and XhoI (pCMV-chodl w/o intra-
cellular domain-FLAG), and EcoRI and XbaI (pCMV-chodl w/o CTLD-FLAG).
The zebrafish full-length col19a1 sequence was amplified from pCS-ColXIXeGFP-DEST (gift from Christine Beattie, Ohio, US) us-
ing the following primer sets: forward (ClaI) 50-GCG ATC GAT ACC ATG TTT TCA AGG GGC CCT TTC-30 and reverse (XbaI-HA) 50-
GCG TCT AGA CTA AGCGTA ATC TGG AAC ATC GTA TGGGTA TGG TCC GGGGCC ATC CCG TCT ACC ATA AG-30, and forward
(SfiI) 50- GCGGGCCCAGCCGGCCGAGAGAAT AGA TCA TAC ATG TCC-30 and reverse (SacII) 50-GCG CCGCGGCTAGCC ATC
CCGTCT ACCATA AG-30. ClaI-XbaI-digested and SfiI-SacII-digested colXIXa1PCR fragments were subcloned into CMV-MCS vec-
tor (pCMV-co19a1-HA) and pDISPLAY vector (pDISPLAY-HA-col19a1), respectively. The TSPN domain of col19a1 was obtained by
PCR (forward 50- GCG GGG CCC AGG AGA GAA TAG ATC ATA CAT GTC C-30 and reverse 50- GCG CCG CGG CTA TGC TGT GGG
GTT GTG GGT C-30) and subcloned into the ApaI-SacII-digested pDISPLAY vector (pDISPLAY-HA-TSPN). To generate the
pDISPLAY-HA-NC-Col plasmid, the NC-Col region was digested with BglII and NotI from pDISPLAY-HA-col19a1 and religated
into pDISPLAY vector.
For the construction of pCMV-colXIIa1-HA the MCS of pCMV-MCS vector was replaced by a new cloning site containing the SbfI
and NheI restriction enzyme sites, and the HA-tag sequence (forward EcoRI 50- AAT TCC CTG CAG GCC CTT AAG CCC GCT AGC
CCC GGA CCA TAC CCA TAC GAT GTT CCA GAT TAC GCT TAG G-30 and reverse BamHI 50- GAT CCC TAA GCG TAA TCT GGA
ACA TCGTATGGGTATGGTCCGGGGCTAGCGGGCTTAAGGGCCTGCAGGG-30). Full-length zebrafish col12a1aCDSwas cut
from the previously described hsp70l:col12a1a-p2A-cerulean construct (Wehner et al., 2017) and religated into the SbfI-NheI new
CMV-MCS digested vector.
The mnx1 promoter was amplified from genomic DNA using the forward primer (NotI) 50- GCG GCGGCC GCC CAT TTA AAT TAG
CCT GGC ATC TGG AC-30 and reverse primer (EcoRI) 50-GCG GAA TTC TCT GGC CCA CCT CAC AAA CAG-30), and the fragment
was cloned into the NotI-EcoRI pminiTol2 digested vector (pminiTol2-mnx1). The chodl-FLAG-SV40pA fragment, amplified from the
pCS2P-chodl-FLAG (forward EcoRI 50- GCGGAA TTC AAC ATGCGCGCGACACTC AGG-30 and reverse EcoRV 50- GCGGAT ATC
AAA AAA CCT CCC ACA C-30), was sub-cloned into the EcoRI-EcoRV-digested pminiTol2-Mnx1 vector. The pCS2P-chodl-FLAG
plasmid was generated by amplifying the chodl coding sequence from pCMV-chodl-myc, adding an artificial Kozak sequence
(AAC) 50 of the start site and adding a Gly-Pro-Gly linker and a synthetic FLAG tag to the 30end (forward EcoRI 50-GCG GAA TTC
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TGG GAC CTC CAT GCC ACT-30). The amplified chodl-FLAG fragment was digested and ligated into the EcoRI-XhoI-digeste
pCS2P+ vector.
To generate chodl w/o intracellular domain (ID), the chodl coding sequence until the transmembrane domain (TMD) was amplified
and a linker with FLAG-tag added, using the pCS2P-chodl-FLAG as template (forward EcoRI 50-ATG CGA ATT CAA ACA TGC GCG
CGACACTCAGG-30 and reverse XhoI 50-GCA TCTCGAGTTACT TGTCGTCATCGTCTT TGTAGTCAGGGCCAGGGAAACAGC
ACG TCC CTG AAG-30). This fragment was sub-cloned into the pCS2P+ vector and used as a PCR template to add the SV40
sequence for ligation into the pminiTol2-mnx1 plasmid (forward EcoRI 50-GAT TCG AAT TCA AAC ATGCGCG-30 and reverse EcoRV
50-CGA TGA TAT CAA AAA ACC TCC CAC ACC TCC C-30).
To generate an expression vector for Chodl w/o C-type lectin domain (CTLD), two intermediate chodl fragments were generated 50
and 30 of the CTLD (Cassette 1 forward EcoRI 50-ATG CGA ATT CAA ACA TGC GCG CGA CAC TCA GG-30 and reverse XhoI 50-GCA
TCT CGA GCA CTG TCT GAC CGC TCA CAA 30, and Cassette 2 forward XhoI 50-ATG CCT CGA GTA TGA ACC AGA AAG TCA TCT
GG-30and reverse XbaI 50-GCA TTC TAG ATT ACT TGT CGT CAT CGT CTT TGT AGT CAG GGC CAG GGA CCT CCA TGC CAC-30).
The PCR products were ligated together into the digested pCS2P+ vector, and then the whole chodl cassette and SV40 amplified to
ligate into pminiTol2-mnx1 vector. The primers for this amplification are the same as previously used to generate the final cassette of
the chodl w/o ID.
To generate chodl w/ ST- > A ID, the intracellular sequence 30 of the transmembrane domain wasmutagenized using PCR primers.
A sequence of 4 primers were used, which first bound to the TMD and added 30bp of mutagenized sequence, then bound to the last
20bp of each successivemutagenized sequence and added another 30bp. The final primer also contained the Gly-Pro-Gly linker and
FLAG-tag sequence. In each case, the forward primer was the same. Forward EcoRI 50-ATGCGAATTCAAACA TGCGCGCGACAC
TCAGG-30, Reverse 1 50-AGC TTT AGCCCG TGG TTT AGCCTT AGCCAACAT CTGGAA ACAGCACGT CCC TGA AG-30, Reverse
2 50-CGTCTT AGCGATCCAGAGAGCAGCTTGGTTGACAGCAGCTTT AGCCCGTGGTTT AGC-30, Reverse 3 50-GACCTCCAT
GCC AGC GTC TAT CTT AGC CGT CTT AGC GAT CCA GAG AG-30, Reverse 4 50-GCA TCT CGA GTT ACT TGT CGT CAT CGT CTT
TGT AGT CAG GGC CAG GGA CCT CCA TGC CAG CGT C-30. As described for the other truncated constructs, the cassette was
ligated into the pCS2P+ vector and re-amplified with the SV40 sequence, and ligated into the pminiTol2-mnx1 vector.
To generate the pminiTol2-mnx1-LifeactEGFP plasmid, the LifeactEGFP fragment was generated by PCR (Forward EcoRI 50- GCG
GAA TTC AAC ATG GGA GTA GCA GAC CTA ATC-30 and Reverse EcoRV 50- GCG GAT ATC TAA GAT ACA TTG ATG AGT TTG
GAC-30) and ligated into the pminiTol2-mnx1 vector. All generated plasmid were fully or partially sequenced.
Generation of a chodl mutant zebrafish
Three gRNAs targeting exon 1 of chodlwere designed using http://zlab.bio/guide-design-resources (Ran et al., 2013). The top guides
were selected for estimated cutting efficiency and fewest off-target sites, and for a restriction site to use in genotyping. Oligonucle-
otides for these gRNA sequences were generated using http://ZiFit.partners.org/ website to insert into the pT7-gRNA expression
vector. Oligos were annealed and ligated into the pT7 vector as described elsewhere (Jao et al., 2013).
gRNA was transcribed using the mMessage mMachine T7 Transcription kit (Thermo Fisher) after the plasmids were linearized with
BamHI. gRNAs were purified using the mirVana miRNA Kit (Thermo Fisher). The Cas9 mRNA was prepared from the pCS2-nCas9n
plasmid (gift fromWenbiao Chen, addgene plasmid #47929), linearized with XbaI and transcribed using the mMessage mMachineT3
Transcription Kit. Each gRNAwas co-injected with cas9mRNA into single-cellmnx1:GFP embryos, at an injection volume of 1nl. The
final injected gRNA concentration was 15 ng/ul and the Cas9 mRNA concentration was 150 ng/ul.
At 24 hpf, the embryos were checked for normal gross morphology and motor axon appearance. In each injection clutch, 5 em-
bryos were pooled for DNA extraction and genotyping to determine cutting efficiency of the gRNA target sequence. G0 injected fish
for gRNA1 were raised and outcrossed into the WIK wild-type fish line. F1 adults were fin-clipped and genotyped for heterozygous
mutation in the target sequence. Two founders had deletions of DCTCA, and one with DACACT in exon1 of chodl, leading to frame-
shift mutations and premature stops in exon 2. The two DCTCA founders were incrossed and had a heterogeneous clutch of moto-
neuron GFP+ and GFP offspring. In the mnx1:GFP+ embryos, 25% of the clutch showed a shortened axon phenotype. These
phenotypically identified mutant embryos were selected and raised to generate homozygous mutant stocks, and some were taken
to sequence their DNA and confirm homozygosity of the indel. For the GFP offspring, homozygous mutant adults were selected
from their non-homozygous siblings by genotyping through fin-clipping. The shortened axon phenotype in these fish was later
confirmed by SV2 staining in their offspring.
Generation of trasngenic zebrafish line
chodl mutant embryos were injected at the single-cell stage with 1nl of a mixture of transposase mRNA (50ng/ml, pT3TS-Tol2, gift
from Stephen Ekker, Addgene plasmid # 31831) and pminoTol2-mnx1:chodl-FLAG (25ng/ml) dissolved in RNase-free water. At 24
hpf, embryos were selected that showed a mosaic rescue of axon lengths. These fish were raised and backcrossed into the
chodl mutant line, with F1 embryos selected that showed rescue of virtually all motor axons at 24 hpf. Transmission of the
mnx1:chodl-FLAG transgene was also confirmed using FLAG immunohistochemistry on the embryos at 24 hpf.Cell Reports 29, 1082–1098.e1–e10, October 29, 2019 e5
Zebrafish DNA extraction and genotyping
Embryos were digested whole using a solution containing 2.5ul Proteinase K (Invitrogen), 10 ml Taq polymerase buffer (New England
Biolabs), and 90 ml water. Embryos were heated to 65C for 20 min, homogenized, and then heated to 95C for 15 mins. The solution
was then homogenized again, spun down and 40ul of supernatant were removed for use as a PCR template.
Adult zebrafish fins were cut by first anaesthetising the fish in 1:1000 MS-222 (Sigma) and cutting off a small portion of fin using a
clean scalpel blade. The fin was digested in the same buffer as the embryos above and heated in the same sequence as for embryo
DNA extraction.
The DNA was amplified using genotyping primers which span a300bp region around the gRNA target sequence. The amplicons
were digested with the restriction enzyme for each target and run on a 2% agarose gel with the undigested amplicon. An undigested
band demonstrates destruction of the restriction site via indel mutations by the Cas9. For gRNA1, which was used to generate the
chodlmutant line, the genotyping primers are: forward 50-GAC TGG AGC AAG TCT GTG-30 and reverse 50-CTG CACGAG ACC AGA
AAA-30, with BspCNI as the restriction site.
Zebrafish qRT-PCR
mRNA was extracted from 28 hpf zebrafish embryos (100 embryos/group/experiment) according to the manufacturer’s instructions
(RNeasy Mini Kit, QIAGEN). cDNA was synthesized using the iScript cDNA Synthesis Kit (Bio-Rad). Reverse transcription-PCR was
performed using the following pair of primers (Table S2) flanking a 232bp region between exon 5 and 7: 50-ACCACCCACTGATGAG
GATG-30 and reverse 50- GACCTCCATGCCACTGTCTA-30. Beta-actin was used as loading control (forward 50- CACTGAGGC
TCCCCTGAATCCC-30, reverse 50- CGTACAGAGAGAGCACAGCCTGG-30). All the amplicons were run a 1.5% agarose gel.
qRT-PCR was performed using the SsoAdvanced Universal SYBR Green Supermix kit according to the manufacturer’s instructions
(BioRad). Samples were run in triplicates on a LightCycler 96 instrument (Roche). The data wwereas analyzed using the LightCycler
96 application software v1.1 (Roche). Expression level of chodl was normalized to beta-actin control.
Double-morpholino injections in zebrafish
Approximately 1 nL of morpholino solution was injected into the yolk of mnx1:GFP transgenic animals and motor axon morphology
was evaluated as shortened or not at 24 hpf, as described (Zhong et al., 2012). Morpholino doses were titrated to be subthreshold for
phenotype generation (shortened axons). Total morpholino load per egg was kept constant by filling up with standard control mor-
pholino (GeneTools, Philomath, OR, USA).
Acute rescue assays of motor axon length in zebrafish
25ng/ml of plasmid coding for Chodl without ID (pminiTol2-mnx1:chodl-FLAG w/o ID), Chodl without CTLD (pminiTol2-mnx1:chodl-
FLAGw/o CTLD) or Chodl with mutated residues in the ID (pminiTol2-mnx1:chodl-FLAG ST- > A) was co-injected with 50ng/ml mRNA
transposase (pT3TS-Tol2) into chodl mutant embryos at the single-cell stage (final volume: 1 nl). As negative control for microinjec-
tion, empty pminiTol2-mnx1 was used, while pMiniTol2-mnx1:chodl-FLAG was used as positive control for rescue. At 28hpf, the
embryoswere dechorionated, fixed, and immunohistochemistry for GFP and FLAGwas performed. Axon length wasmeasured using
ImageJ, presence of FLAG expression was determined by fluorescence microscopy. Axons were only considered FLAG positive if
the FLAG staining was visible along the full length of the axon, if the neuronal morphology matched that of the CaP neuron, with its
soma situated directly above the peripheral axon, as described (Myers et al., 1986). This avoided mistakenly measuring motor axons
from RoP or MiP primary motor neurons. Images were analyzed in a blinded fashion.
Zebrafish whole-mount immunohistochemistry
Between 24 and 30 hpf, the zebrafish embryos were dechorionated and fixed for 45min at room temperature in 4%PFA / 1%DMSO.
This under-fixation is necessary to detect the low signal in the synapse preparations and the injected FLAG constructs. The embryos
were then rinsed 3x5mins with PBS + 0.1% Triton X-100 and blocked using blocking buffer containing 1% normal donkey serum (1%
DMSO, 1% BSA, 0.7% Triton X-100 in PBS pH 7.4) for 60 – 90 min at room temperature with gentle shaking. The embryos were then
incubated overnight at 4C with the primary antibodies in blocking buffer with 1% normal donkey serum. Primary antibodies were:
anti-GFP (1:400, AbCam, AB13970), anti-FLAG (1:100, Sigma, F1804), anti-SV2 (1:200, DSHB), anti-Znp-1 (1:100, DSHB) and anti-
AChR (1:200, DSHB, mAb35). The primary antibodies were washed off using PBS-Tx for 6 3 10 min and the secondary antibody
incubated for 4 h at room temperature. Secondary antibodies used were: AlexaFluor488 donkey anti-chicken (1:400, Jackson
ImmunoResearch), AlexaFluor 594 donkey anti-mouse (1:400 Jackson ImmunoResearch), AlexaFluor 594 donkey anti-mouse
with pre-adsorption against rat protein (1:400, Jackson ImmunoResearch), AlexaFluor 488 donkey anti-rat with pre-adsorption
against mouse protein (1:400, Jackson ImmunoResearch) and AlexaFluor 647 donkey anti-rat with pre-adsorption against mouse
protein (1:400, Jackson ImmunoResearch). After fully rinsing off the secondary antibody, the embryos were settled in 70% glycerol /
30% PBS and stored wrapped in foil at 4C until imaging.
At 3dpf, the larvae were fixed in 4% PFA / 1%DMSO for 4 h at 4C. After 33 10 min rinsing in PBS + 0.1% Triton X-100, the larvae
were skinned to make the muscle more accessible to antibody labeling. The larvae were fixed to a silicone-coated Petri dish with
insect pins and most of the liquid sucked away from the larvae. Sharpened tungsten wire was used to gently pull the skin away
from the head area, and fine forcepswere then used to fully pull the skin off the trunk and tail. After skinning, the larvaewere incubatede6 Cell Reports 29, 1082–1098.e1–e10, October 29, 2019
for 60 - 90 min in blocking buffer as described above at room temperature. Primary and secondary antibodies were used at the same
concentrations and incubation time as described for the embryos.
Zebrafish phalloidin staining and analysis
At 30 hpf, zebrafish embryos were dechorionated and fixed overnight at 4C. After washes with PBS+Tween (0.1%), the embryos
were permeabilised by incubation in PBS+Triton X-100 (2%) for 2 h at room temperature. After further brief washes in PBS +
0.1% Tween-20, the embryos were incubated in PBS + 0.1% Tween + 5% AF568 Phalloidin (Thermofisher). After washing using
PBS+0.1% Tween-20, the embryos were settled in 70% glycerol / 30% PBS before imaging.
A single optical plane was analyzed which showed the full somite, and the number of distinct muscle cells per somite counted. The
average width of each muscle cell was also measured. For each embryo, images of three somites were analyzed with the observer
blinded to the genotype.
Zebrafish whole-mount confocal imaging
All zebrafish were mounted onto glass slides using 70% glycerol, deyolked with insect pins, and covered with coverslips anchored
with silicone gel. Images were acquired using a Zeiss LSM880 Indimo, Axio examiner confocal microscope with Plan-Apochromat
20x/0.8 objective.
Synaptic puncta quantification in zebrafish
All measurement of the synaptic puncta, labeled by SV2, Syt2 and AChR antibodies, was performed in ImageJ (Schneider et al.,
2012). For analysis, an approximate 400 mm2 square (20x20) was drawn around the horizontal myoseptum in 28 hpf embryos,
with 4 - 5 axons measured and the values averaged for each embryo. To determine synaptic measurements in the axonal branches
at 3 dpf, a 1600 mm2 square (40x40) was drawn in the ventral region of the myotome, with the top edge of the ROI 40 mm ventral to the
horizontal myoseptum, with 3 myotomes averaged per larva.
In each square, the synaptic compartment was analyzed by performing background subtraction of the images, with a rolling ball
radius of 33% of the square’s length in pixels. A 30% threshold was applied to all channels. Threshold values were calculated from
the maximum gray value measured from a smoothed duplicated image. After application of the threshold, the Analyze Puncta func-
tion was used to count puncta number and area (outline mask was generated). The minimum area defined as a punctum for the
Analyze Particle function was set as 0.6 mm2. This was qualitatively determined as the minimum size to remove background noise
without loss of true puncta.
The outlinemask was used to create a ROImask. The ROImask was applied on the raw images (after background subtraction) and
the mean gray value was measured. The observer was blinded to the experimental condition before measuring.
Time-lapse imaging of axon filopodia in zebrafish
Embryos containing mnx1-LifeactEGFP expressing CaP axons were mounted in 1 - 1.2% low melting agarose with 0.01% tricaine
(MS-222). Images were acquired using a Zeiss LSM 880 confocal laser scanning microscopy with Airyscan and a Plan-Apochromat
20x/0.8 objective. Z stack (space 0.500 mm) were collected every 30 s over a period of 60 min. Fiji software was used to quantify the
number and the lifetime of filopodia in each frame of each time-lapse sequence. The lifetime of filopodia was defined as the length of
time for which its presence was detected during imaging. Three wild-type and three chodl mutants were analyzed (one axon/fish).
The observer was blinded to the genotype while performing measurements.
Analysis of MiP motor axons in zebrafish
33hpf zebrafish embryos were fixed and stained for endogenous EGFP (anti-GFP, 1:400, AbCam, AB13970) and znp-1 (anti-Znp-1,
1:100, DSHB). Secondary antibodies used were: AlexaFluor488 donkey anti-chicken (1:400, Jackson ImmunoResearch) and
AlexaFluor 594 donkey anti-mousewith pre-adsorption against rat protein (1:400, Jackson ImmunoResearch). Imageswere acquired
using a Zeiss LSM880 Indimo, Axio examiner confocal microscope with Plan-Apochromat 20x/0.8 objective. Five to six MiP motor
axons per embryo were scored for extending beyond the dorsal border of the spinal cord, as described (Zhong et al., 2012) . During
measurements the observer was blinded to the genotype.
Zebrafish larval behavior analysis
To analyze swimming distance, 3 dpf larvae were touched on the median fin fold with a fire-pulled pipette. The swim path of their
escape response was recorded and analyzed using a Noldus behavior analysis set-up and EthoVision software (v. 7). Behavioral
data are shown as distance traveled within 15 s after touch, averaged for triplicate measures per larvae.
To measure turning angles, we recorded larvae using a Casio EX-ZR1300 camera with high-speed recording set to 1000 frames /
second. Larvae were recorded before, during, and after an escape response from a head tap with a fire-pulled glass pipette. The
larvae were touched on the tip of their nose and they subsequently turned randomly to the left or right to escape the stimulus.
The angle of the initial escape after the C-bend was binned into 45 segments from the starting position without considering the
direction of the bending. The escape response was recorded in triplicate per larva.Cell Reports 29, 1082–1098.e1–e10, October 29, 2019 e7
To analyze the number of spontaneous contractions, 18-19hpf embryos were recorded continuously for 5 min under a stereomi-
croscope equipped with a GXCAM 1.3 camera and the number of coiling movements counted. The videos were recorded using the
GX Capture software at a speed of 6.2-5.3 frames/second (resolution 1272x952).
All behavioral experiments and analyses of videos were done in a blinded fashion.
Genotyping PCR for mice
Genomic DNA (gDNA) was prepared using PureLink Genomic DNA Kit (Invitrogen) according to the manufacturer’s instruction.
Founder mice were identified by genotyping PCR using HotStarTaq DNA polymerase (QIAGEN) with 2 gene-specific primer pairs
(pair A: 50- ACGTGAGTTTAGAGGGAAAGTTTG 30 and 50- CAGGATTGGCAGTTGGTTGGT 30; pair B: 50-GGCTGGCTTGT
GAAAGTGAAG-30 and 50-GTTTGGCCATCTCCGCTTCT-30). Both the primers were used for routine genotyping.
Mouse primary motor neuron cell culture
Primary motor neurons were isolated from the lumbar spinal cords of E12.5-13 WT and Chodl/ homozygous embryos by using a
p75NTR-panning protocol (Wiese et al., 2010). Briefly, the lumbar region (L1-L6 segment) of the spinal cord was dissected from each
embryo and enriched on laminin and Poly-dl-ornithine hydrobromide (Sigma) -coated plates in neurobasal medium (Invitrogen) con-
taining GlutaMAX I supplemented with 10% heat-inactivated horse serum (Sigma) and 5 ng/ml brain derived neurotrophic factor
(BDNF; PeproTech) and ciliary neurotrophic factor (CNTF; PeproTech). Motor neurons were plated till 5 days in vitro. The cells
were fixed with 4% paraformaldehyde in phosphate buffered saline (PBS) for 15 min at room temperature, washed three time
with PBS 1X for 5 min, and stored at 4◦C.
Immunohistochemistry
The samples were incubated with the immunofluorescence (IF) blocking buffer (0.01% Triton X-100/TBS and 10% normal serum) for
1 h at room temperature andwashed once with IF buffer (0.01%Triton X-100/TBS). After blocking, the cells were incubated overnight
at 4C with the primary antibodies diluted in IF buffer: rabbit anti-Tuj1 (Covance, 1:2000) and mouse anti-Islet1 (DSHB, 1:50), After
washing steps the cells were incubated for 1 h at room temperature with the appropriate secondary antibodies: Alexa Fluor 488 and
Alexa Fluor 568 (Invitrogen, 1:500), washed twice and counterstainedwith DAPI for nucleus staining beforemountedwith Vectashield
Hard Set (Vector) Mounting Medium. Fluorescence was visualized using a confocal microscope Zeiss LSM.
Quantifications
All measurements of the neuronal morphologies were performed using automated WIS-NeuroMath software (Rishal et al., 2013).
Neurite lengths, branching, cell body area and other parameters were calculated and saved for each cell, while ignoring neurites
which were not attached to cell bodies or attached to excessively small or large cell bodies. The cell body size was calculated using
threshold-based segmentation using the same software.
Ex vivo electrophysiology in mice
Experimental procedures on 4 months-old mice were performed as described previously (Webster et al., 2013). Phrenic nerve/hemi-
diaphragm preparations were bathed in Krebs-Henseleit buffer: 95%O2 / 5%CO2. Experiments took place in a Faraday enclosure at
room temperature (20 – 22C). Phrenic nerve was stimulated with a solid-state square wave pulse generator (Grass Instruments,
Quincy, MA, USA) via a suction electrode. The signal was amplified using an Axoclamp 900A amplifier (Molecular Devices, Sunny-
vale, CA, USA). Compound muscle action potential (CMAP; example traces in Figure S7I-K) was recorded with a low resistance
extracellular glass electrode, containing bath solution, placed close to central area of the muscle. Recordings of CMAPs were
made prior to blockade of muscle sodium channels. Blockade of muscle contraction was achieved with 2.5 mM m-conotoxin GIIIB
(Alomone labs, Jerusalem, Israel). A borosilicate glass electrode (10–15 MU resistance, filled with 3M KCl) was used for recording
miniature endplate potentials (MEPPs) and evoked endplate potentials (EPPs) from individual muscle fibers. A micromanipulation
rig (Scientifica, Maidenhead, UK) was used to place electrodes as near to the endplate region as possible, with visualization under
a BX51WI stereomicroscope (Olympus, Southend-on-Sea, UK). Recordingswere analyzed using pCLAMP 9 software (Molecular De-
vices), and normalized to a 80 mV baseline, thus correcting for differences in resting membrane potential. For each preparation
12-15 fibers were impaled, 30 mEPPs over were acquired and averaged. EPPS were recorded at 1 Hz stimulation frequency, 20
EPPS were acquired and averaged for each fiber. Data from each preparation (up to 15 fibers) were averaged, each n represents
a single preparation. For determination of quantal content, EPP amplitude was subjected the further species-specific correction,
as follows:
AMPEPP = AMPEPP ðmeasuredÞ





Where AMPEPP is the EPP amplitude, 0.8 the correction factor for mouse endplates, and E the resting membrane potential (80 mV).
Quantal content was calculated according to the following formula:
Quantal content = meanðAMPEPPÞ= meanðAMPMEPPÞ
Where AMPMEPP is the MEPP amplitude.
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Mouse muscle preparation and immunohistochemistry
Mice were sacrificed, muscles dissected, and neuromuscular junctions immunohistochemically labeled and observed as previously
described (Sleigh et al., 2014b). Muscles were dissected in cold 1 3 phosphate-buffered saline (PBS) and fixed in 4% (w / v) para-
formaldehyde in PBS (PFA, Electron Microscopy Sciences) for 15 min. Initially the muscles were permeabilized with 2% Triton X-100
in PBS for 30 min, before blocking in 4% bovine serum albumin and 1% Triton X-100 in PBS for 30 min and then incubated overnight
at 4C in blocking solution with appropriate primary antibodies against neurofilament (2H3, 1/50, DSHB); synaptic vesicles (SV2,
1/100, DSHB); mouse anti-bassoon, 1:500 (cat. no. GTX13249, SAP7F407, Source BioScience, Nottingham, UK); rabbit anti-piccolo,
cat. no. 142002, 1:200, and rabbit anti-P/Q-VGCC (Cav2.1), cat. no. 152203, 1:300 (Synaptic Systems, Göttingen, Germany). The
next day, muscles were washed three times with PBS before a 2-hours incubation with secondary antibodies (1:250, Invitrogen,
varieties of Alexa Fluor-488 conjugated, 568-conjugated and 1.5 mg/ml tetramethylrhodamine (TRITC) a-BTX (Cambridge Biosci-
ence) in PBS. Finally, muscles were washed three times in PBS for 30 min and mounted in hard set Vectashield (Vector labs) on glass
slides with DAPI for confocal imaging.
Images were acquired using a Zeiss LSM 710 confocal microscope. Morphometric analysis of neuromuscular junctions was car-
ried out using a standardized platform: ‘‘NMJ-morph’’ (Jones et al., 2016). In vivo axon branching was measured from processed
binary images generated in ImageJ. Pixel positions of skeletonized imageswere used in quantifying branching patterns using a binary
connectivity plugin. Experiments were done blinded with mice identified only by codes and earclip number until all testing was
completed.
Behavioral analysis in mice
Open field testing was performed using PAS Homecage (San Diego Instruments) for a period of 20 min. The means of two trials were
analyzed per time point. Accelerating rotarod (Med Associates; 4–40 rpm) was performed to amaximum trial length of 300 s. Tested 2
times each day, over 3 separate days (2 3 3), average of 6 replicates used for final analysis.
The four-limb hanging wire test was conducted using a 43 cm2 grip-grid secured above a padded surface. Each trial was per-
formed for a maximum of 120 s, or until the mice fell before the time was up. The mean of six trials per mouse was analyzed per
time point. Behavioral testing was performed at monthly intervals without knowledge of the genotype.
HEK293T transfection and binding assays
HEK293T cells were platted at a density of 1.5x105 cells / 100 mm dish and transfected with 8 - 10 mg plasmid DNA using standard
CaPO4 transfection (Kwon and Firestein, 2013).
For immunofluorescence experiments, HEK293T cells were plated on poly-D-lysine coverslips and transfectedwith 0.5 mg plasmid
DNA using Lipofectamine2000 (Invitrogene) according to themanufacturers’ instructions. At 24 h post-transfection, the mediumwas
replaced with serum-free medium containing ColXIXa1 or ColXIIa1a, and further incubated for 24 h.
Immuno-labeling of transfected HEK293T cells
For immunostaining of Chodl, col19a1 and col12a1a, transfected HEK293T cells were fixed for 10min in 4% PFA / 4% glucose, per-
meabilized (0,3% Triton X-100 in PBS) and blocked for 1 h at room temperature in blocking solution (1% BSA, 1% NGS, 0.1x Triton
X-100 in PBS). Cells were incubated overnight at 4C in primary antibodies (anti-HA, 1:400, BioLegend, Clone 16B12, and anti-FLAG
1:200, Cell Signaling, D6W5B). Following the washing steps, cells were incubated for 40 min at room temperature in secondary an-
tibodies (1:400, Alexa Fluor 647 donkey anti-rabbit, Jackson ImmunoResearch, 1:400, Alexa Fluor 488 donkey anti-mouse, Jackson
ImmunoResearch, and 1:400, Alexa Fluor 647 donkey anti-mouse, Jackson ImmunoResearch). Coverslips were extensively washed,
mounted in Mowiol and let dry overnight before imaging. Binding at the cell surface was measured on a single plane using the profile
tool from ZenBlue 2.3 software. Data were exported in Excel and the scatterplot was generated. Analysis was done on two different
batches of HEK293T transfected cells. Two different coverslips per transfection batch were imaged and analyzed.
Protein binding assays
HEK293T cells transfected with FLAG-tagged constructs were lysed for 1h in ice cold lysis buffer (50mM HEPES pH7.5,
150mM NaCl, 1% Triton X-100) supplemented with proteinase inhibitors (Roche), followed by a short centrifugation step at
14000rpm / 10min / 4C. The clear supernatant was either incubated for 1h with FLAG M2 magnetic beads (Sigma) to collect the
overexpressed Chodl or directly mixed with purified HA-tagged ColXIXa1. HA-tagged ColXIXa1 was produced and secreted by
HEK293T cells in the presence of 50 mg/ml ascorbic acid. The cell culture medium was concentrated using VIVASPIN concentrators
(MWCO 50000), followed by purification via HAmagnetic beads (Thermo Scientific). All the binding assays were performed at 4C for
2 h on a rotator. After incubation, the beads were extensively washed with lysis buffer and boiled at 95C / 5 min in Laemmli buffer
supplemented with b-ME. Proteins were resolved in SDS-PAGE gel and transferred to nitrocellulosemembrane (Bio Rad). The detec-
tion of proteins was performed using primary antibodies against HA (1:1000, BioLegend, Clone 16B12) and FLAG (1:1000, Sigma,
F1804, or Cell Signaling, D6W5B), and secondary antibodies IRDye 800CW goat anti-mouse IgG (1:1000, Li-Cor) and IRDye
680LT goat anti-rabbit IgG (1:10000, Li-Cor). Membranes were scanned using the Odyssey Fc imaging system.Cell Reports 29, 1082–1098.e1–e10, October 29, 2019 e9
QUANTIFICATION AND STATISTICAL ANALYSIS
All quantitative data were tested for normality and analyzed with parametric and non-parametric tests as appropriate. For multiple
comparisons, we used: One-way ANOVA with Tukey’s Multiple Comparison Test (Figures 1D, 2B, 2C, 2D, 2G, 3K, 3N, 5C, S1H,
and S3B), Kruskal-Wallis test with Dunn’s multiple comparison test (Figures 1B, 2E, 2F, 2H, 2I, 5F, S1M, and S3C) or two-way
ANOVA with Sidak’s multiple comparisons test (Figures S7A, S7B, and S7D–S7H). For single comparisons, we used: unpaired
t test (Figures 4C–4N, S1E, S2C, S2E, S3E–S3O, S4C, S5E–S5H, S6C, S6E, and S6L–S6M), Mann–Whitney U tests (Figures S1F
and S4E) or one sample t test (Figure 6D; Figure S1I).
Statistical power was calculated using G*Power (Faul et al., 2009) (aim for most experiments > 0.8; indicated in Figure legends).
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; n.s. indicates no significance (p > 0.05). Error bars indicate the standard error of the
mean (SEM). The Figures were prepared with Adobe Photoshop CC and Adobe Illustrator CC/ Adobe Photoshop and Adobe Illus-
trator Creative Cloud. Graphs were generated using GraphPad Prism 7/GraphPad Prism 8.01.
DATA AND CODE AVAILABILITY
Original Coomassie and western blot data used to generate any of the figure panels in the paper are available on Mendeley Data
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